Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
NUCLEOTIDE SEQUENCES WHICH CODE FOR THE OPCA GENE
The invention provides nucleotide sequences which code for
the opcA gene and a process for the fermentative
preparation of amino acids, in particular L-lysine using
coryneform bacteria in which the opcA gene is amplified.
Prior art
Amino acids, in particular L-lysine, are used in human
medicine and in the pharmaceuticals industry, but in
particular in animal nutrition.
1o It is known that amino acids are prepared by fermentation
from strains of coryneform bacteria, in particular
Corynebacterium glutamicum. Because of their great
importance, work is constantly being undertaken to improve
the preparation processes. Improvements to the processes
can relate to fermentation measures, such as e. g. stirring
and supply of oxygen, or the composition of the nutrient
media, such as e. g. the sugar concentration during the
fermentation, or the working up to the product form by
e. g. ion exchange chromatography, or the intrinsic output
2o properties of the microorganism itself.
Methods of mutagenesis, selection and mutant selection are
used to improve .the output properties of these
microorganisms. Strains which are resistant to
antimetabolites, such as e. g. the lysine analogue S-(2-
~aminoethyl)-cysteine, or are auxotrophic for metabolites of
regulatory importance and produce L-amino acids, such as
e. g. h-lysine, are obtained in this manner. Methods of the
recombinant DNA technique have also been employed for some
years for improving the strain of Corynebacterium strains
3o which produce amino acids.
The importance of the pentose phosphate cycle for the
biosynthesis is known.
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
Z
Thus Oishi and Aida (Agricultural and Biological Chemistry
29, 83-89 (1965)) already report on the "hexose
monophosphate shunt" of Brevibacterium ammoniagenes.
Sugimoto and Shio (Agricultural and Biological Chemistry
S1, 101-108 (1987)) report on the regulation of glucose 6-
phosphate dehydrogenase in Brevibacterium flavum. Sugimoto
and Shio (Agricultural and Biological Chemistry S1, 1257-
11263 (1987)) report on the regulation of glucose 6-
phosphate dehydrogenase in Brevibacterium flavum.
1o JP-A-09229661 discloses the nucleotide sequence of the
glucose 6-phosphate dehydrogenase gene, called zwf, of
Brevibacterium flavum MJ-223 (FERM BP-1997). JP-A-09229661
describes the N-terminal amino acid sequence of the Zwf
polypeptide as Met Val Ile Phe Gly Val Thr Gly Asp Leu Ala
Arg Lys Lys Leu.
However, it has not been possible to confirm this.
Object of the invention
The inventors had the object of providing new measures for
improved fermentative preparation of amino acids, in
2o particular L-lysine.
Description of the invention
Amino acids, in particular L-lysine, are used in human
medicine, in the pharmaceuticals industry and in particular
in animal nutrition. There is therefore a general interest
in providing new improved processes for the preparation of
amino acids, in particular L-lysine.
When L-lysine or lysine are mentioned in the following, not
only the base but also the salts, such as e. g. lysine
monohydrochloride or lysine sulfate, ate also meant by ,
3o this .
CA 02348365 2001-03-08
WO 01/04322 PGT/EP00/06300
3
The invention provides an isolated polynucleotide from
coryneform bacteria, comprising at least one polynucleotide
sequence chosen from the group consisting of
a) polynucleotide which is identical to the extent of at.
~ 5 least 70 % to a polynucleotide which codes for
polypeptides which comprise at least one of the amino
acid sequences according to SEQ ID No. 3 or SEQ ID No. 5
or SEQ ID No. 8 or SEQ ID No. 10,
b) polynucleotide which codes for polypeptides which
io comprise amino acid sequences which are identical to the
extent of at least 70 % to the amino acid sequences
according to SEQ ID No.3 or SEQ ID No. 5 or according to
SEQ ID No. 8 or SEQ ID No. 10,
c) polynucleotide which is complementary to the
i5 polynucleotides of a) or b), or
d) polynucleotide comprising at least 15 successive
nucleotides of the polynucleotide sequences of a), b)
or c) .
The invention also provides the polynucleotide as claimed
2o in claim 1, this preferably being a DNA which is capable of
replication, comprising:
(i) one or more nucleotide sequences) chosen from
the group consisting of SEQ ID No. 1, SEQ ID
No. 4, SEQ ID No. 6, SEQ ID No. 9, or
25 (ii) at least one sequence which corresponds to
sequence (i) within the range of the degeneration
of the genetic code, or
(iii) at least one sequence which~hybridizes with the
sequence complementary to sequence (i) or (ii),
3o and optionally
(iv) sense mutations of neutral function in (i)~.
CA 02348365 2001-03-08
W O O1 /04322 PCT/EP00/06300
y
The invention also provides
a polynucleotide as claimed in claim 4, comprising the
nucleotide sequence as shown in SEQ ID No. 9 or SEQ ID
No. 9,
a polynucleotide as claimed in claim 6, which codes for a
polypeptide which comprises at least one of the amino
acid sequences as shown in SEQ ID No. 3, SEQ ID No. 5,
SEQ ID No. 8 or SEQ ID No. 10,
a vector containing the polynucleotide as claimed in
to claim 1,
and coryneform bacteria, serving as the host cell, which
contain the vector.
The invention also provides polynucleotides which
substantially comprise a polynucleotide sequence, which are
obtainable by screening by means of hybridization of a
corresponding gene library, which comprises the complete
gene with the polynucleotide sequence corresponding to SEQ
ID No. 4 or SEQ ID No. 9, with a probe which comprises the
sequence of the polynucleotide mentioned, according to SEQ
2o ID No. 4 or SEQ ID No. 9 or a fragment thereof, and
isolation of the DNA sequence mentioned.
Polynucleotide sequences according to the invention are
suitable as hybridization probes for RNA, cDNA and DNA, in
-order to isolate, in the full length, cDNA which code for
OpcA protein and to isolate those cDNA or genes which have
a high similarity of sequence with that of the opcA gene.
Polynucleotide sequences according to the invention are
furthermore suitable as primers for the preparation of DNA
of genes which code for OpcA protein by the polymerase
3o chain reaction (PCR).
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
S
Such oligonucleotides which serve as probes or primers
comprise at least 30, preferably at least .20, especially
preferably at lease 15 successive nucleotides.
Oligonucleotides which have a length of at least 90 or 50
nucleotides are also suitable.
"Isolated" means separated out of its natural environment.
"Polynucleotide" in general relates to polyribonucleotides
and polydeoxyribonucleotides, it being possible for these
to be non-modified RNA or DNA or modified RNA or DNA.
"Polypeptides" is understood as meaning peptides or
proteins which comprise two or more amino acids bonded via
peptide bonds.
The polypeptides according to the invention include a
polypeptide according to SEQ ID No. 3, SEQ ID No. 5, SEQ ID
No. 8 or SEQ ID No. 10, in particular those with the
biological activity of the OpcA gene product, and also
those which are identical to the extent of at least 70 % to
the polypeptide according to SEQ ID No. 3, SEQ ID No. 5,
SEQ ID No. 8 or SEQ ID No. 10, and preferably are identical
2o to the extent of at least 80% and in particular to the
extent of at least 90 % to 95 % to the polypeptide
according to SEQ ID No. 3, SEQ ID No. 5, SEQ ID No. 8 or
SEQ ID No. 10, and have the activity mentioned.
The invention also provides the new Zwf protein which forms
the Zwf sub-unit of glucose 6-phosphate dehydrogenase. The
amino acid sequence of the translation product is shown in
SEQ ID no. 2 and SEQ ID No. 7. The N-terminal amino acid
sequence of the Zwf sub-unit, which can be isolated, of
glucose 6-phosphate dehydrogenase is shown in SEQ ID No.
11 .
The invention also provides a process for the fermentative
preparation of amino acids, in particular L-lysine, using
coryneform bacteria which in particular already produce an
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300 ,
6
amino acid, and in which the nucleotide sequences which
code for the opcA gene are amplified, in particular over-
expressed, optionally together with the zwf gene.
The term "amplification" in this connection describes the
increase in the intracellular activity of one or more
enzymes (proteins) in a microorganism which are coded by
the corresponding DNA, for example by increasing the number
of copies of the gene or genes, using a potent promoter or
using a gene which codes for a corresponding enzyme
(protein) having a high activity, and optionally combining
these measures.
The microorganisms which the present invention provides can
prepare L-amino acids, in particular L-lysine, from
glucose, sucrose, lactose, fructose, maltose, molasses,
is starch, cellulose or from glycerol and ethanol. They can be
representatives of coryneform bacteria, in particular of
the genus Corynebacterium. Of the genus Corynebacterium,
there may be mentioned in particular the species
Corynebacterium glutamicum, which is known among experts
2o for its ability to produce L-amino acids.
Suitable strains of the genus Corynebacterium, in
particular of the species Corynebacterium glutamicum, are,
for example, the known wild-type strains
Corynebacterium glutamicum ATCC13032
25 Corynebacterium acetoglutamicum ATCC15806
Corynebacterium acetoacidophilum ATCC13870
Corynebacterium thermoaminogenes FERM Bp-1539
Corynebacterium melassecola ATCC17965
Brevibacterium flavum ATCC14067
30 Brevibacterium lactofermentum ATCC13869 and
Brevibacterium divaricatum ATCC19020
and L-lysine-producing mutants or strains prepared
therefrom, such as, for example
CA 02348365 2001-03-08
WO O1/0432Z PCT/EP00/06300
Corynebacterium glutamicum FERM-P 1709
Brevibacterium flavum FERM-P 1708
Brevibacterium lactofermentum FERM-P 1712
Corynebacterium glutamicum FERM-P 6463
Corynebacterium glutamicum FERM-P 6964 and
Corynebacterium glutamicum DSM5715
Corynebacterium glutamicum DM58-1
Corynebacterium glutamicum DSM12866.
and L-threonine-producing mutants or strains prepared
1o therefrom, such as, for example
Corynebacterium glutamicum ATCC21649
Brevibacterium flavum BB69
Brevibacterium flavum DSM5399
Brevibacterium lactofermentum FERM-Bp 269
Brevibacterium lactofermentum TBB-10
and L-isoleucine-producing mutants or strains prepared
therefrom, such as, for example
Corynebacterium glutamicum ATCC 14309
Corynebacterium glutamicum ATCC 19310
Corynebacterium glutamicum ATCC 14311
Corynebacterium glutamicum ATCC 15168
Corynebacterium ammoniagenes ATCC 6871
and L-tryptophan-producing mutants or strains prepared
therefrom, such as, for example
Corynebacterium glutamicum ATCC21850 and
Corynebacterium glutamicum KY9218(pKW9901)
The inventors have succeeded in isolating the new opcA gene
of C. glutamicum which codes for the OpcA sub-unit of the
enzyme glucose 6-phosphate dehydrogenase (EC 2.7.1.11).
3o To isolate the opcA gene or also other genes of C.
glutamicum, a gene library of this microorganism is first
CA 02348365 2001-03-08
WO 01/04312 PCT/EP00/06300 ,
set up in E. coli. The setting up of gene libraries is
described in generally known textbooks and handbooks. The
textbook by Winnacker: Gene and Klone, Eine Einfiihrung in
die Gentechnologie [Genes and Clones, An Introduction to
Genetic Engineering] (Verlag Chemie, Weinheim, Germany,
1990) or the handbook by Sambrook et al.: Molecular
Cloning, A Laboratory Manual (Cold Spring Harbor Laboratory
Press, 1989) may be mentioned as an example. A very well-
known gene library is that of the E. coli K-12 strain W3110
1o set up in ~, vectors by Kohara et al. (Cell 50, 495 -508
(1987)). Bathe et al. (Molecular and General Genetics,
252:255-265, 1996) describe a gene library of C. glutamicum
ATCC13032, which was set up with the aid of the cosmid
vector SuperCos I (Wahl et al., 1987, Proceedings of the
National Academy_of Sciences USA, 84:2160-2169) in the
E. coli K-12 strain NM559 (Raleigh et al., 1988, Nucleic
Acids Research 16:1563-1575). Bormann et al. (Molecular
Microbiology 6(3), 317-326)) (1992)) in turn describe a
gene library of C. glutamicum ATCC13032 using the cosmid
2o pHC79 (Hohn and Collins, Gene 11, 291-298 (1980)).
O'Donohue (The Cloning and Molecular Analysis of Four
Common Aromatic Amino Acid Biosynthetic Genes from
Corynebacterium glutamicum. Ph.D. Thesis, National
University of Ireland, Galway, 1997) describes the cloning
of C. glutamicum genes using the ~. Zap expression system
described by Short et al. (Nucleic Acids Research, 16:
7583). To prepare a gene library of C. glutamicum in E.
coli it is also possible to use plasmids such as pBR322
(Bolivar, Life Sciences, 25, 807-818 (1979)) or pUC9
3o (Vieira et al., 1982, Gene, 19:259-268). Suitable hosts
are, in particular, those E. coli strains which are
restriction- and recombination-defective. An example of
these is the strain DH5amcr, which has been described by
Grant et al. (Proceedings of the National Academy of
Sciences USA, 87 (1990) 4645-4649). The long DNA fragments
cloned with the aid of cosmids can then in turn be
subcloned and subsequently sequenced in the usual vectors
and L-isoleucine-producing mutants or
CA 02348365 2001-03-08
WO O1/043Z2 PCT/EP00/06300
9
which are suitable for sequencing, such as is described
e. g. by Sanger et al. (Proceedings of the. National Academy
of Sciences of the United States of America, 74:5463-5967,
1977).
. 5 The DNA sequences obtained can then be investigated with
known algorithms or sequence analysis programs, such as
e. g. that of Staden (Nucleic Acids Research 19, 217-
232(1986)),the GCG program of Butler (Methods of
Biochemical Analysis 39, 74-97 (1998)) the FASTA algorithm
io of Pearson and Zipman (Proceedings of the National Academy
of Sciences USA 85,2444-2448 (1988)) or the BLAST algorithm
of Altschul et al. (Nature Genetics 6, 119-129 (1994)) and
compared with the sequence entries which exist in databanks
accessible to the public. Databanks for nucleotide
15 sequences which are accessible to the public are, for
example, that of the European Molecular Biology
Laboratories (EMBL, Heidelberg, Germany) or that of the
National Center for Biotechnology Information (NCBI,
Bethesda, MD, USA).
2o The invention provides a new DNA sequence of C. glutamicum
which codes for the opcA gene and which is a constituent of
the present invention as SEQ ID NO 1 and SEQ ID NO 4. The
amino acid sequence of the corresponding protein has
furthermore been derived from the present DNA sequence by
25 the methods described above. The resulting amino acid
sequence of the OpcA gene product is shown in SEQ ID NO 3
and SEQ ID NO 5. The molecular weight resulting from the
amino acid sequence of the OpcA gene product is approx.
34.7 kilo dalton.
3o SEQ ID NO 1 also shows the coding region of the zwf gene.
The resulting amino acid sequence of the Zwf gene product
is shown in SEQ ID NO 2. The molecular weight resulting
from the amino acid sequence of the Zwf gene product is
approx. 57.5 kilo dalton.
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
A gene library produced in the manner described above can
furthermore be investigated by hybridization with
nucleotide probes.of known sequence, such as, for example,
the zwf gene (JP-A-09224661). The cloned DNA of the clones
5 which show a positive reaction in the hybridization is
sequenced in turn to give on the one hand the known
nucleotide sequence of the probe employed and on the other
hand the adjacent new DNA sequences.
The invention also provides a new DNA sequence of C.
1o glutamicum which codes for the opcA gene and which is a
constituent of the present invention as SEQ ID N0.6 and SEQ
ID NO 9. The amino acid sequence of the corresponding
protein has furthermore been derived from the present DNA
sequence by the methods described above. The resulting
amino acid sequence of the OpcA gene product is shown in
SEQ ID NO 8 and SEQ ID NO 10. The molecular weight
resulting from the amino acid sequence of the OpcA gene
product is approx. 34.7 kilo dalton.
SEQ ID NO 6 also shows the coding region of the zwf gene.
2o The resulting amino acid sequence of the Zwf gene product
is shown in SEQ ID NO 7. The molecular weight resulting
from the amino acid sequence of the Zwf gene product is
approx. 57.5 kilo dalton.
Another procedure for at least partly determining the amino
acid sequence of the OpcA protein and the Zwf protein
comprises purifying the glucose 6-phosphate dehydrogenase
enzyme protein to homogeneity by chromatographic methods.
Methods and instructions for protein purification and
preparation are described e.g. in the textbook by Schleifer
3o and Wensink: Practical Methods in Molecular Biology
(Springer Verlag, Berlin, Germany, 1981), in the handbook
by Harris and Angal: Protein Purification Methods: A _
Practical Approach (IRL Press, Oxford, UK, 1989),in the
textbook by Scopes: Protein Purification: Principles and
Practice, 3rd ed. (Springer Verlag, New York, USA, 1993)
CA 02348365 2001-03-08
WO 01/04322 PCT/Ep00/06300
and in generally known textbooks and handbooks. The N-
terminal amino acid sequence of the purified polypeptides
can be determined.by the method of N-terminal sequencing
described by Edman (Archives of Biochemistry 22, 475
(1949)). Further methods and instructions for protein
sequencing are described e. g. in Smith: Protein Sequencing
Protocolls: Methods in Molecular Biology, Vol. 69 and Vol.
112 (Humans Press, Totowa, NJ, USA, 1996) and in Kamp et
al.: Protein Structure Analysis: Preparation,
1o Characterization, and Microsequencing (Springer Verlag, New
York, NY, USA, 1997).
It was possible to show in this manner that the enzyme
glucose 6-phosphate dehydrogenase consists of two sub-units
with in each case a molecular weight of approx. 30 kDa and
approx. 60 kDa. The N-terminal amino acid sequence of the
OpcA sub-unit and of the OpcA protein is shown in
SEQ-ID-NO. 12. The N-terminal amino acid sequence of the
Zwf sub-unit and of the Zwf protein is shown in SEQ-ID-
NO. 11.
Coding DNA sequences which result from SEQ ID NO 1, SEQ ID
NO 4, SEQ ID NO 6 or SEQ ID NO 9 by the degeneracy of the
genetic code are also a constituent of the invention. In
the same way, DNA sequences which hybridize with SEQ ID
NO 9 or SEQ ID NO 9 or parts of SEQ ID NO 4 or SEQ ID N0 9
are a constituent of the invention. Conservative amino acid
exchanges, such as e. g. exchange of glycine for alanine or
of aspartic acid for glutamic acid in proteins, are
furthermore known among experts as "sense mutations" which
do not lead to a fundamental change in the activity of the
3o protein, i.e. are of neutral function. It is furthermore
known that changes on the N and/or C terminus of a protein
cannot substantially impair or can even stabilize the
function thereof. Information in this context can be found
by the expert, inter alia, in Ben-Bassat et al. (Journal of
Bacteriology 169:751-757 (1987)), in O'Regan et al. (Gene
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
IZ
77:237-251 (1989)), in Sahin-Toth et al. (Protein Sciences
3:290-247 (1994)), in Hochuli et al. (Bio/Technology
6:1321-1325 (1988).) and in known textbooks of genetics and
molecular biology. Amino acid sequences which result in a
corresponding manner from SEQ ID NO 3, SEQ ID NO 5, SEQ ID
NO 8 or SEQ ID NO 10 are also a constituent of the
invention.
Finally, DNA sequences which are prepared by the polymerase
chain reaction (PCR) using primers which result from SEQ ID
1o NO 4 or SEQ ID NO 9 are a constituent of the invention.
Such oligonucleotides typically have a length of at least
nucleotides.
Instructions for identifying DNA sequences by means of
hybridization can be found by the expert, inter alia, in
15 the handbook "The DIG System Users Guide for Filter
Hybridization" from Boehringer Mannheim GmbH (Mannheim,
Germany, 1993) and in Liebl et al. (International Journal
of Systematic Bacteriology (1991) 41: 255-260).
Instructions for amplification of DNA sequences with the
2o aid of the polymerase chain reaction (PCR) can be found by
the expert, inter alia, in the handbook by Gait:
Oligonukleotide synthesis: a practical approach (IRh Press,
Oxford, UK, 1989) and in Newton and Graham: PCR (Spektrum
Akademischer Verlag, Heidelberg, Germany, 1994).
The inventors have found that coryneform bacteria produce
amino acids, in particular L-lysine, in an improved manner
after over-expression of the opcA gene, optionally together
with the zwf gene.
To achieve an over-expression, the number of copies of the
3o corresponding genes can be increased, or the promoter and
regulation region or the ribosome binding site upstream of
the structural gene can be mutated. Expression cassettes
which are incorporated upstream of the structural gene act
in the same way. By inducible promoters, it is additionally
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
i3
possible to increase the expression in the course of
fermentative L-lysine production. The expression is
likewise improved by measures to prolong the life of the rn-
' RNA. Furthermore,~the enzyme activity is also increased by
preventing the degradation of the enzyme protein. The genes
or gene constructs can either be present in plasmids with a
varying number of copies, or can be integrated and
amplified in the chromosome. Alternatively, an over-
expression of the genes in question can furthermore be
1o achieved by changing the composition of the media and the
culture procedure.
Instructions in this context can be found by the expert,
inter alia, in Martin et al. (Bio/Technology 5, 137-196
(1987)), in Guerrero et al. (Gene 138, 35-41 (1994)),
Tsuchiya and Morinaga (Bio/Technology 6, 428-930 (1988)),
in Eikmanns et al. (Gene 102, 93-98 (1991)), in European
Patent Specification EPS 0 472 869, in US Patent 4,601,893,
in Schwarzer and Piihler (Bio/Technology 9, 84-87 ( 1991 ) , in
Reinscheid et al. (Applied and Environmental Microbiology
60, 126-132 (1994)), in LaBarre et al. (Journal of
Bacteriology 175, 1001-1007 (1993)), in Patent Application
WO 96/15246, in Malumbres et al. (Gene 134, 15 - 24
(1993)), in Japanese Laid-Open Specification JP-A-10-
229891, in Jensen and Hammer (Biotechnology and
Bioengineering 58, 191-195 (1998)), in Makrides
(Microbiological Reviews 60:512-538 (1996)) and in known
textbooks of genetics and molecular biology.
By way of example, the opcA gene according to the invention
was over-expressed with the aid of plasmids.
3o Suitable plasmids are those which are replicated in
coryneform bacteria. Numerous known plasmid vectors, such
as e. g. pZl (Menkel et al., Applied and Environmental
Microbiology (1989) 64: 549-559), pEKExl (Eikmanns et al.,
Gene 102:93-98 (1991)) or pHS2-1 (Sonnen et al., Gene
107:69-74 (1991)) are based on the cryptic plasmids
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
14
pHM1519, pBLl or pGAl. Other plasmid vectors, such as e. g.
those based on pCG4 (US-A 4,489,160), or pNG2 (Serwold-
Davis et al., FEMS Microbiology Letters 66, 119-129
(1990)), or pAGl (US-A 5,158,891), can be used in the same
manner.
The E. coli - C. glutamicum shuttle vector pEC-Tl8mob2
shown in Figure 2 was used as an example. After
incorporation of the opcA gene and the zwf gene into the
SphI/SalI cleavage site region of pEC-Tl8mob2, the plasmid
pECzwfopcA shown in Figure 3 was formed.
Plasmid vectors which are furthermore suitable are also
those with the aid of which the process of gene
amplification by.integration into the chromosome can be
used, as has been described, for example, by Reinscheid et
al. (Applied and Environmental Microbiology 60, I26-132
(1994)) for duplication or amplification of the hom-thrB
operon. In this method, the complete gene is cloned in a
plasmid vector which can replicate in a host (typically E.
coli), but not in C. glutamicum. Possible vectors are, for
example, pSUP301 (Simon et al., Bio/Technology 1, 784-791
(1983)), pKlBmob or pKl9mob (Sch~fer et al., Gene 145,
69-73 (1999)), pGEM-T (Promega corporation, Madison, WI,
USA), pCR2.1-TOPO (Shaman (1994). Journal of Biological
Chemistry 269:32678-89; US-A 5,487,993), pCR~Blunt
(Invitrogen, Groningen, Holland; Bernard et al., Journal of
Molecular Biology, 234: 534-541 (1993)), pEMl (Schrumpf et
al, 1991, Journal of Bacteriology 173:4510-4516) or pBGSB
(Spratt et a1.,1986, Gene 41: 337-342). The plasmid vector
which contains the gene to be amplified is then transferred
3o into the desired strain of C. glutamicum by conjugation or
transformation. The method of conjugation is described, for
example, by Sch~fer et al. (Applied and Environmental
Microbiology 60, 756-759 (1999)). Methods for
transformation are described, for example, by Thierbach et
al. (Applied Microbiology and Biotechnology 29, 356-362
CA 02348365 2001-03-08
WO 01/04322
PCT/EP00/06300
(1988)), Dunican and Shivnan (Bio/Technology 7, 1067-1070
(1989)) and Tauch et al. (FEMS Microbiological Letters 123,
. 393-397 (1994)). After homologous recombination by means of
a "cross over" event, .the resulting strain contains at
least two copies of the gene in question.
In addition, it may be advantageous for the production of
amino acids, in particular L-lysine, to amplify or over-
express one or more enzymes of the particular biosynthesis
pathway, of glycolysis, of anaplerosis, of the pentose
to phosphate pathway or of amino acid export, in addition to
the opcA gene, optionally together with the zwf gene.
Thus, for example, for the preparation of L-lysine, it may
be advantageous for one or more genes chosen from the group
consisting of
~ the dapA gene which codes for dihydrodipicolinate
synthase (EP-B 0 197 335),
~ the lysC gene which codes for a feed back resistant
aspartate kinase (Kalinowski et al. (1990), Molecular and
General Genetics 224: 317-329),
~ the gap gene which codes for glycerolaldehyde 3-phosphate
dehydrogenase (Eikmanns (1992), Journal of Bacteriology
179 : 6076-6086) ,
~ the pyc gene which codes for pyruvate carboxylase (DE-A-
198 31 609),
~ the tkt gene which codes for transketolase (accession
number AB023377 of the databank of European Molecular
Biology Laboratories (EMBL, Heidelberg, Germany)),
~ the gnd gene which codes for 6-phosphogluconate
dehydrogenase (JP-A-9-229662),
~ the lysE gene which codes for lysine export
(DE-A-195 98 222),
CA 02348365 2001-03-08
WO 01!04322 PCT/EP00/06300 '
l6 -
~ the zwal gene (DE 199 59 328.0; DSM 13115), or
~ the eno gene which codes for enolase (DE: 199 91 478.5),
~ the tal gene which codes for transaldolase (DSM 13263)
to be amplified, in particular over-expressed, at the same
time.
It may furthermore be advantageous for the production of
amino acids, in particular L-lysine, at the same time to
attenuate
~ the pck gene which codes for phosphoenol pyruvate
1o carboxykinase (DE 199 50 409.1 DSM 13047) and/or
~ the pgi gene which codes for glucose 6-phosphate
isomerase (US 09/396,478, DSM 12969), or
~ the poxB gene which codes for pyruvate oxidase
(DE 199 51 975.7; DSM 13114), or
~ the zwa2 gene (DE: 199 59 327.2; DSM 13113)
in addition to the amplification of the opcA gene,
optionally in combination with the zwf gene.
In addition to over-expression of the opcA gene it may
furthermore be advantageous for the production of amino
2o acids, in particular L-lysine, to eliminate undesirable
side reactions (Nakayama: "Breeding of Amino Acid Producing
Micro-organisms", in: Overproduction of Microbial Products,
Krumphanzl, Sikyta, Vanek (eds.), Academic Press, London,
UK, 1982).
The microorganisms prepared according.to the invention can
be cultured continuously or discontinuously in the batch
process (batch culture) or in the fed batch (feed process)
or repeated fed batch process (repetitive feed process) for
the purpose of production of L-amino acids, in particular
CA 02348365 2001-03-08
WO 01/04322
PCT/EP00/06300
L-lysine. A summary of known culture methods are described
in the textbook by Chmiel (Bioprozesstechnik 1. Einfuhrung
in die Bioverfahrenstechnik [Bioprocess Technology 1,
Introduction to Bioprocess Technology (Gustav Fischer
Verlag, Stuttgart, 1991)) or in the textbook by Storhas
(Bioreaktoren and periphere Einrichtungen [Bioreactors and
Peripheral Equipment) (Vieweg Verlag,
Braunschweig/Wiesbaden, 1994)).
The culture medium to be used must meet the requirements of
1o the particular strains in a suitable manner. Descriptions
of culture media for various microorganisms are contained
in the handbook "Manual of Methods for General
Bacteriology" of the American Society for Bacteriology
(Washington D.C., USA, 1981). Sugars and carbohydrates,
such as e. g. glucose, sucrose, lactose, fructose, maltose,
molasses, starch and cellulose, oils and fats, such as
e~ g. soya oil, sunflower oil, groundnut oii and coconut
fat, fatty acids, such as e. g. palmitic acid, stearic acid
and linoleic acid, alcohols, such as e. g. glycerol and
2o ethanol, and organic acids, such as e. g. acetic acid, can
be used as the source of carbon. These substance can be
used individually or as a mixture. Organic nitrogen-
containing compounds, such as peptones, yeast extract, meat
extract, malt extract, corn steep liquor, soya bean flour
and urea, or inorganic compounds, such as ammonium
sulphate, ammonium chloride, ammonium phosphate, ammonium
carbonate and ammonium nitrate, can be used as the source
of nitrogen. The sources of nitrogen can be used
individually or as a mixture. Phosphoric acid, potassium
3o dihydrogen phosphate or dipotassium hydrogen phosphate or
the corresponding sodium-containing salts can be used as
the source of phosphorus. The culture medium must
furthermore comprise salts of metals, such as e. g.
magnesium sulfate or iron sulfate, which are necessary for
growth. Finally, essential growth substances, such as amino
acids and vitamins, can be employed in addition to the
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
18
above-mentioned substances. Suitable precursors can
moreover be added to the culture medium. The starting
substances mentioned can bc- added to the culture in the
form of a single batch, or can be fed in during the culture
in a suitable manner.
Basic compounds, such as sodium hydroxide, potassium
hydroxide, ammonia or aqueous ammonia, or acid compounds,
such as phosphoric acid or sulfuric acid, can be employed
in a suitable manner to control the pH. Antifoams, such as
1o e. g. fatty acid polyglycol esters, can be employed to
control the development of foam. Suitable substances having
a selective action, such as e. g. antibiotics, can be added
to the medium to maintain the stability of plasmids. To
maintain aerobic conditions, oxygen or oxygen-containing
gas mixtures, such as e. g. air, are introduced into the
culture. The temperature of the culture is usually 20°C to
95°C, and preferably 25°C to 40°C. Culturing is continued
until a maximum of L-amino acid has formed. This target is
usually reached within 10 hours to 160 hours.
2o The analysis of L-amino acids can be carried out by anion
exchange chromatography with subsequent ninhydrin
derivatization, as described by Spackman et al. (Analytical
Chemistry, 30, (1958), 1190).
The following microorganism has been deposited at the
Deutsche Sammlung fiir Mikroorganismen and Zellkulturen
(DSMZ = German Collection of Microorganisms and Cell
Cultures, Braunschweig, Germany) in accordance with the
Budapest Treaty:
~ Corynebacterium glutamicum ATCC13032/pECzwfopcA as
3o DSM 13264
SEQ ID NO 1 also contains the new devB gene. The process
according to the invention is used for the fermentative
preparation of amino acids, in particular L-lysine.
CA 02348365 2001-03-08
WO 01/04322
~9
Sequences attached:
PCT/EP00/06300
The following sequences are attached in the form of a
' sequence protocol:
SEQ ID NO: Description:
DNA sequence isolated from Corynebacterium
glutamicum ATCC13032
2 Amino acid sequence of the Zwf protein
derived from SEQ ID NO 1
Amino acid sequence of the OpcA protein
1o derived from SEQ ID NO 1
DNA sequence of the opcA gene of ATCC13032
taken from SEQ ID NO 1
Amino acid sequence of the OpcA protein
derived from SEQ ID NO 4
15 6 DNA sequence isolated from Corynebacterium
glutamicum AS019
Amino acid sequence of the Zwf protein
derived from SEQ ID NO 6
Amino acid sequence of the OpcA protein
20 derived fxom SEQ ID NO 6
DNA sequence of the opcA gene of AS019
taken from SEQ ID NO 6
Amino acid sequence of the OpcA protein
derived from SEQ ID NO 9
25 11 Amino acid sequence of the N-terminus of the
Zwf protein of the glucose 6-phosphate
dehydrogenase from ATCC13032 which can b
e
isolated
12 Amino acid sequence of the N-terminus of the
3o OpcA protein of the glucose 6-phosphate
dehydrogenase, which can be isolated
from
,
ATCC13032
CA 02348365 2001-03-08
WO 01/04322 PGT/EP00/06300 ,
The following figures are attached:
Figure 1: Map of the plasmid pBOB102
Figure 2: Map of the plasmid pEC-Tl8mob2
Figure 3: Map of the plasmid pECzwfopcA
5 The abbreviations used have the following meaning:
Figure 1:
Neo r . Neomycin/kanamycin resistance
ColEl ori: origin of replication of plasmid ColEl
CMV: Cytomegalovirus promoter
1o lace: promotor of lac operon
lacZ: 5'-end of b-galactosidase gene (lacZa
gene fragment)
SV90 3' splice 3' splice site of Simian Virus 90
SV90 polyA: polyadenylation site of Simian Virus 40
15 fl(-)ori: origin of replication of
filamentousphage fl
SV40 ori: origin of replication of Simian Virus
40
Figures 2 and 3:
2o Tet: Resistance gene for tetracycline
oriV: Plasmid-coded replication origin of E. coli
RP9mob: mob region for mobilizing the plasmid
rep: Plasmid-coded replication origin from C.
glutamicum plasmid pGAl
per: Gene for controlling the number of copies
from PGA1
lacZ-alpha: lacZa gene fragment (N-terminus) of the (3-
galactosidase gene
lacZalpha': 5'-Terminus of the lacZa gene fragment
'lacZalpha: 3'-Terminus of the lacZa gene fragment
zwf: zwf gene
opcA: opcA gene
CA 02348365 2001-03-08
WO 01/04322
Z!
PCT/EP00/06300
Further abbreviations:
ApaI: cleavage site of restriction enzyme ApaI
BamHI: cleavage site of restriction enzyme amHI
ClaI: cleavage site of restriction B ClaI
S EcoRI: cleavage site of restriction enzyme EcoRI
HindIII: cleavage site of restriction enzyme HindIII
MstII: cleavage site of restriction enzyme MstII
NheI: cleavage site of restriction enzyme NheI
NsiI: cleavage site of restriction enzyme NsiI
io SacI: cleavage site of restriction enzyme SacI
SalI: cleavage site of restriction enzyme SalI
SpeI: cleavage site of restriction enzyme SpeI
SphI: cleavage site of restriction enzyme SphI
SspI: cleavage site of restriction enzyme SspI
15 XbaI: cleavage site of restriction enzyme XbaI
enzyme
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00J06300
22
Examples
The following examples will further illustrate this
invention. The molecular biology techniques, e.g. plasmid - '
DNA isolation, restriction enzyme treatment, legations,
standard transformations of Escherichia coli etc. used are, -
(unless stated otherwise), described by Sambrook et al.,
(Molecular Cloning. A Laboratory Manual (1989) Cold Spring
Harbour Laboratories, USA).
Example 1
io Construction of a gene library of Corynebacterium'
glutamicum strain AS019
A DNA library of Corynebacterium glutamicum strain AS019
(Yoshihama et al., Journal of Bacteriology 162, 591-597
(1985) ) was constructed using ~. Zap Express'''' system,
(Short et al., (1988) Nucleic Acids Research, 16: 7583-
7600), as described by O'Donohue (O'Donohue, M. (1997). The
Cloning and Molecular Analysis of Four Common Aromatic
Amino Acid Biosynthetic Genes from Corynebacterium
glutamicum. Ph.D. Thesis, National University of Ireland,
2o Galway. ) . ~, Zap Express'''' kit was purchased from Stratagene
(Stratagene, 11011 North Torrey Pines Rd., La Jolla,
California 92037.) and used according to the manufacturers
instructions. AS019-DNA was digested with restriction
enzyme Sau3A and legated to BamHI treated and
dephosphorylated ~, Zap Expressz''' arms .
Example 2
Cloning and sequencing of the opcA and zwf gene
1. Construction of a zwf probe
A radiolabelled oligonucleotide, internal to the zwf gene,
3o was used to probe the AS019 ~, Zap ExpressT" library
described above. The oligonucleotide was produced using
degenerate PCR primers internal to the zwf gene. The
CA 02348365 2001-03-08
WO 01/04322 PC'T/EP00/06300
23
degenerate nucleotide primers designed for the PCR
amplification of zwf DNA fragments were as- follows:
~ zwfl: 5' ATY GAY CAC TAY YTS GGY AAR GA 3'
zwf2: 5' RAA WGG MAC RCC YKS CCA 3'
with R=A+G; Y=C+T; W=A+T; M=A+C; S=G+C; K=T+G.
The estimated size of the resulting PCR product was 480bp
approximately.
Optimal PCR conditions were determined to be as follows:
35 cycles
99°C for 1 minute
60°C for 1 minute
72°C for 30 seconds
2.5, - 3.5 mM MgClZ
100 - 150 ng AS019 genomic DNA
Sequence analysis of the resulting PCR product confirmed
the product to be an internal portion of the zwf gene.
Sequence analysis was carried out using the universal
forward and reverse primers, and T7 sequencing kit from
Pharmacia Biotech, (St. Albans, Herts, UK).
2. Cloning
Screening of the AS019 7~ Zap Express'' library was carried
out according to the ~, Zap Express'''' system protocol,
5
(Stratagene, 11011 North Torrey Pines Rd., La Jolla,
California 92037.). Southern Blot analysis was then carried
out on isolated clones. Southern transfer of DNA was as
described in the Schleicher and Schuell protocols manual
employing NytranT''' as membrane ("Nytran, Modified Nylon-66
Membrane Filters" (March 1987), Schleicher and Schuell,
Dassel, Germany). Double stranded DNA fragments, generated
3o using the same primers and optimal PCR conditions as
described above, were radiolabelled with a.-32P-dGTP using
the Multiprime~'' DNA labelling kit from Amersham Life
CA 02348365 2001-03-08
WO 01104322 PCT/EP00/06300
24
Science (Amersham Pharmacia Biotech UK Limited, Little
Chalfont, Buckinghamshire, UK) according to the
manufacturers instructions. Prehybridisation, hybridization
and washing conditions were as described in the Schleicher
and Schuell protocols manual. Autoradiography was carried
out according to the procedure outlined in the handbook of '
Sambrook et al. using AgFa Curix RPIL film. Thus several
zwf clones were identified. Plasmid DNA was isolated from
one of the clones, designated pB08102 (Figure 1) and chosen
for further analysis.
3. Sequencing
The Sanger Dideoxy chain termination method of Sanger et
al. (Proceedings of the National Academy of Sciences USA
79, 5463-5967 (1977)) was used to sequence the cloned
i5 insert of pBOH102. The method was applied using the T7
sequencing kit and a-35S-dCTP from Pharmacia Biotech (St.
Albans, Herts, UK). Samples were electrophoresed for 3-8
hours on 6% polyacrylamide/urea gels in TBE buffer at a
constant current of 50 mA, according to the Pharmacia
2o cloning and sequencing instructions manual ("T' Sequencingz'r'
Kit",ref.XY-010-00-19, Pharmacia Biotech, 1999). Initial
sequence analysis was carried out using the universal
forward and M13 reverse primers obtained from Pharmacia
Biotech:
25 Universal forward
primer: 5' GTA ATA CGA CTC ACT ATA GGG C 3'
M13 reverse primer: 5' GGA AAC AGC TAT GAC CAT G 3'
Internal primers were subsequently designed from the
sequence obtained which allowed the entire opcA gene to be
30 deduced. The sequences of the internal primers were as
follows
Internal primer 1: 5' TCA ACC CTG AGT CCA CC 3'
Internal primer 2: 5' CTG ACC ACG AGC GGA GG 3'
Internal primer 3: 5' ATG GTG ATC TGG ACG TG 3'
CA 02348365 2001-03-08
WO 01/04321
PCT/EP00/06300
ZS
Internal primer 4: 5' CTG GCG ACT TGG CTC GA 3'
Internal primer S: 5' CTT CCG GAT ACC ACC ACC 3'
Sequence obtained~was then analyzed using the DNA Strider
programme, (Marck (1988), Nucleic Acids Research 16: 1829-
1836), version 1.0 on an Apple Macintosh computer. This
program allowed for analyses such as restriction site
usage, open reading frame analysis and codon usage
determination. Searches between DNA sequence obtained and
those in EMBL and Genbank databases were achieved using the
io BLAST programme, (Altschul et al., (1997) Nucleic Acids
Research, 25: 3389-3402). DNA and protein sequences were
aligned using the Clustal V and Clustal W programs (Higgins
and Sharp, 1988 Gene 73: 237-249).
The sequence thus obtained is shown in SEQ ID NO 6. The
is analysis of the nucleotide sequence obtained revealed an
open reading frame of 957 base pairs which was designated
as opcA gene. It codes for a protein of 319 amino acids
shown in SEQ ID NO 8 and SEQ ID NO 10. The coding region of
the zwf gene is also shown in SEQ ID NO 6. The amino acid
2o sequence of the Zwf-Protein composed of 519 amino acids is
shown in SEQ ID NO 7.
Example 3
Preparation of a genomic cosmid gene library from
Corynebacterium glutamicum ATCC 13032
25 Chromosomal DNA from Corynebacterium glutamicum ATCC 13032
was isolated as described by Tauch et al. (1995, Plasmid
33:168-179) and partly cleaved with the restriction enzyme
Sau3AI (Amersham Pharmacia, Freiburg, Germany, Product
Description Sau3AI, Code no. 27-0913-02). The DNA fragments
3o were dephosphorylated with shrimp alkaline phosphatase
(Roche Molecular Biochemicals, Mannheim, Germany, Product
Description SAP, Code no. 1758250). The DNA of the cosmid.
vector SuperCosl (Wahl et al. (1987) Proceedings of the
CA 02348365 2001-03-08
WO 01/04322 pCT/Epp0~p6300
2~
National Academy of Sciences USA 84:2160-2169), obtained
from Stratagene (La Jolla, USA, Product Description
SuperCosl Cosmid Vector Kit, Code no. 251301) was cleaved
with the restriction enzyme XbaI (Amersham Pharmacia,
Freiburg, Germany, Product Description XbaI, Code no.
27-0948-02) and likewise dephosphorylated with shrimp
alkaline phosphatase. The cosmid DNA was then cleaved with
the restriction enzyme BamHI (Amersham Pharmacia, Freiburg,
Germany, Product Description BamHI, Code no. 27-0868-04).
1o The cosmid DNA treated in this manner was mixed~with the
treated ATCC13032 DNA and the batch was treated with T4 DNA
ligase (Amersham Pharmacia, Freiburg, Germany, Product
Description T4-DNA-Ligase, Code no.27-0870-04). The
ligation mixture was then packed in phages with the aid of
i5 Gigapack II XL Packing Extracts (Stratagene, La Jolla, USA,
Product Description Gigapack II XL Packing Extract, Code
no. 200217). For infection of the E. coli strain NM554
(Raleigh et al. 1988, Nucleic Acid Research 16:1563-1575)
the cells were taken up in 10 mM MgSO, and mixed with an
2o aliquot of the phage suspension. The infection and titering
of the cosmid library were carried out as described by
Sambrook et al. (1989, Molecular Cloning: A laboratory
Manual, Cold Spring Harbor), the cells being plated out on
LB agar (Lennox, 1955, Virology, 1:190) with 100 pg/ml
25 ampicillin. After incubation overnight at 3?°C, recombinant
individual clones were selected.
Example 4
Isolation and sequencing of the opcA and zwf gene of ATCC
13032
3o The cosmid DNA of an individual colony was isolated with
the Qiaprep Spin Miniprep Kit (Product No. 27106, Qiagen,
Hilden, Germany) in accordance with the manufacturer's
instructions and partly cleaved with the restriction enzyme
Sau3AI (Amersham Pharmacia, Freiburg, Germany, Product
35 Description Sau3AI, Product No. 27-0913-02). The DNA
CA 02348365 2001-03-08
I WO Ol/04322
PCT/EP00/06300
2~
fragments were dephosphorylated with shrimp alkaline
phosphatase (Roche Molecular Biochemicals,.Mannheim,
Germany, Product Description SAP, Product No. 1758250).
After separation by gel electrophoresis, the cosmid
fragments in the size range of 1500 to 2000 by were
isolated with the QiaExII Gel Extraction Kit (Product No.
20021, Qiagen, Hilden, Germany). The DNA of the sequencing
vector pZero-l, obtained from Invitrogen (Groningen,
Holland, Product Description Zero Background Cloning Kit,
Product No. K2500-O1) was cleaved with the restriction
enzyme BamHI (Amersham Pharmacia, Freiburg, Germany,
Product Description BamHI, Product No. 27-0868-09). The
ligation of the cosmid fragments in the sequencing vector
pZero-1 was carried out as described by Sambrook et al.
(1989, Molecular Cloning: A laboratory Manual, Cold Spring
Harbor), the DNA mixture being incubated overnight with T4
ligase (Pharmacia Biotech, Freiburg, Germany). This
ligation mixture was then electroporated (Tauch et al.
1994, FEMS Microbiol. Letters, 223:343-7) into the E. coli
strain DHSaMCR (Grant, 1990, Proceedings of the National
Academy of Sciences U.S.A:; 87:4645-4699) and plated out on
hB agar (Lennox, 1955, Virology, 1:190) with 50 pg/ml
zeocin. The plasmid preparation of the recombinant clones
was carried out with Biorobot 9600 (Product No. 900200,
Qiagen, Hilden, Germany). The sequencing was carried out by
the dideoxy chain-stopping method of Sanger et al. (1977,
Proceedings of the National Academy of Sciences U.S.A.,
74:5463-5467) with modifications according to Zimmermann et
~al. (1990, Nucleic Acids Research, 18:1067). The "RR
3o dRhodamin Terminator Cycle Sequencing Kit" from PE Applied
Biosystems (Product No. 403049, Weiterstadt, Germany) was
used. The separation by gel electrophoresis and analysis of
the sequencing reaction were carried out in a "Rotiphoresis
NF Acrylamide/Bisacrylamide" Gel (29:1)~(Product No.
A124.1, Roth, Karlsruhe, Germany) with the "ABI Prism 377"
sequencer from PE Applied Biosystems (Weiterstadt,
Germany).
CA 02348365 2001-03-08
WO 01/04322 PCT/Ep00/06300
28
The raw sequence data obtained were then processed using
the Staden program package (1986, Nucleic Acids Research,
19:217-231) version 97-0. The individual sequences of the
pZerol derivatives were assembled to a continuous contig.
The computer-assisted coding region analysis were prepared
with the XNIP program (Staden, 1986, Nucleic Acids
Research, 14:21?-231). Further analyses were carried out
with the "BLAST search programs" (Altschul et al., 1997,
Nucleic Acids Research, 25:3389-3402), against the non-
1o redundant databank of the "National Center for
Biotechnology Information" (NCBI, Bethesda, MD, USA).
The nucleotide sequence obtained is shown in SEQ ID NO 1.
Analysis of the nucleotide sequence showed a coding region
of 957 base pairs, which was called the opcA gene. The opcA
gene, including its stop codon, is shown in SEQ ID NO 4.
The opcA gene codes for a protein of 319 amino acids shown
in SEQ ID NO 3 and SEQ ID NO 5.
Example 5
Purification and N-terminal sequencing of the glucose-6-
2o phosphate dehydrogenase of Corynebacterium glutamicum
ATCC13032.
1. Culture of strain ATCC 13032
For purification of the glucose-6-phosphate dehydrogenase
Corynebacterium glutamicum ATCC 13032 was grown aerobically
on minimal medium at 30°C in a Labfors fermentation system
(Infors AG, Bottmingen, Switzerland). A preculture (Bacto~
Brain Heart Infusion medium, Difco Laboratories, Detroit,
USA) was incubated for 15 hours at 30°C and used for
inoculation of 2.5 1 minimal medium. The medium contained
3o the following constituents (amounts per liter): 20 g
(NH4) 2S04; 1 g KHZP09; 1 g K2HP04; 0. 25' g MgSO~ x 7 H20; 10
mg CaCl2; 0.2 mg biotin: 30 mg protocatechuic acid: 1 mg
FeS04x 7 H20: 1 mg MnSO,x H20; 0.1 mg ZnSO, x 7 HZO; 0.02 mg
CuSO,; 0.002 mg NiCl2 x 6 H20; 1.2 g HC1; 0.2 g
CA 02348365 2001-03-08
WO 01/04322
PCT/EP00/06300
29
polypropylene glycol; 75 mg tritriplex II and 100 g
glucose. During fermentation sodium hydroxide was
continuously added-in order to keep the pH-value constant
at 7Ø The cells were harvested in the late exponential
growth phase. After centrifugation using an Avanti J-25
' centrifuge and a JA10 rotor of Beckman (Fullerton, USA) at
6400 g for 15 minutes at 9°C and washing in 100 mM TRIS-HC1
pH 7.5 containing 10 mM MgCl2 the sediment was stored at
-20°C until use.
2. Enzyme purification
Disruption of cells was carried out in a disintegration
system (Disintegrator S, HIOmatic, Rodgau-Hainhausen,
Germany). The cells were previously resuspended in a pH 7,5
buffer consisting of 100 mM TRIS-HC1, 10 mM MgCl2, 0,75 mM
DTT and a mixture of several protease inhibitors
(complete, Roche, Mannheim, Germany). The ratio of the
cell wet weight to the total suspension weight was adjusted
to 0.3. After addition of 100 ml glass beads with a
diameter of 0.1 to 0.25 mm (Fisher scientific, Diisseldorf,
2o Germany) per 100 ml total suspension volume, cell
disruption was performed at 5000 rpm for 12 Minutes. A
temperature increase during disruption was prevented by ice
cooling. After removal of glass beads an ultracentifugation
step was carried through using an T,8-70 M centrifuge and a
Ti45 rotor of Beckman (Fullerton, USA) at 235000 g for 90
minutes at 4°C. The supernatant was used as crude extract
for the purification of the glucose-6-phosphate
dehydrogenase. All purification steps were carried out with
a Biosys2000 system of Beckman (Fullerton, USA).
3o The crude extract was applied to an XK 50/30 column
(Pharmacia, Freiburg, Germany), which contained Fractogel
EMD DEAF-650(S) material (Merck, Darmstadt). The total bed
volume was 500 ml. The column was previously equilibrated
with 50 mM TRIS-HC1 pH 7.5 containing 30 mM MgCl2 and 0.75
mM DTT. After application of the crude extract the column
CA 02348365 2001-03-08
WO Ol/04322 PCT/EP00/06300 -
was washed with the same buffer containing 144 mM KC1.
Elution was performed within 95 minutes by a linear KC1
gradient from 194 mM up to 320 mM. The flow rate was 7.4
ml/min. The active~fractions were pooled and concentrated
5 in centriprep~ 30 concentrators (Amicon, Beverly, LISA)
using a Varifuge 3. OR centrifuge (Heraeus, Hanau, Germany)
at 1500 g and 9°C. By dilution with 50 mM TRIS-HC1 pH 7.5
containing 30 mM MgCl2 and 0.75 mM DTT the KC1
concentration was adjusted to 40 mM. After that the
1o partially purified glucose-6-phosphate dehydrogenase was
applied to an XK2~!20 column (Pharmacia, Freiburg,
Germany), which was filled with 65 ml Red-Sepharose CL68
(Pharmacia, Freiburg, Germany). The column was equilibrated
with 50 mM TRIS-HC1 pH 7.5 containing 30 mM MgCl2 and 0.75
15 mM DTT. Elution was carried out within 590 minutes by a
linear 0 - 800 mM KC1 gradient at a flow rate of 0.87
ml/min.
After pooling of the active glucose-6-phosphate
dehydrogenase fractions, the KC1 concentration was reduced
20 to 10 mM in the same way as described above. After that the
solution was applied to an XK16/20 column (Pharmacia,
Freiburg, Germany), which contained 20 ml of a 2'S'-ADP-
sepharose matrix (Pharmacia, Freiburg, Germany). The column
was equilibrated with the same buffer as the Red-Sepharose
25 CL6B column. Elution was performed by an 0 to 2 mM NADP
linear gradient. The active glucose-6-phosphate
dehydrogenase-fractions were pooled and applied to a gel
.filtration column.
For gel filtration a Superdex G200pg column (Pharmacia,
30 Freiburg, Germany) with a diameter of 1,6 cm and a bed
volume of 114 ml was used. The elution at a flow rate of 1
ml/min was carried through With 50 mM ,TRIS-HCl pH 7.5
containing 30 mM MgCl2, 200 mM KC1 and 0.75 mM DTT. The
active fractions were pooled and concentrated by
ultrafiltration in centriprep~ 30 concentrators (Amicon,
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
3!
Beverly, USA). After addition of 50 $ (v/v) glycerol to the
purified glucose-6-phosphate dehydrogenase.solution it was
stored at -20°C.
During the whole purification process the glucose-6-
phosphate-dehydrogenase activity and the protein
concentration were measured.
The assay system for determination of the glucose-6-
phosphate-dehydrogenase-activity contained 50 mM TRIS-HC1
pH 7.5, 10 mM MgCl2, 1 mM NADP and 200 mM potassium
glutamate. The reaction was initiated by addition of 4 mM
glucose-6-phosphate and the formation of NADPH was followed
by measuring the increase in absorbance at 340 nm at 30 °C.
Protein concentrations were determined
spectrophotometrically after Coomassie Brilliant Blue
~5 staining (Stoscheck, Methods in Enzymology 182, 50-68
(1990)). As protein standard bovine serum albumin was used.
All measurements were carried out using a UV-160 A
photometer (Shimadzu, Kyoto, Japan).
The purity of the glucose-6-phosphate dehydrogenase was
2o tested by denaturing discontinuous SDS-gelelectrophoresis
according to the method of Laemmli (Laemmli, U.K., Nature
227. 680-685 (1970)). After the third purification step
using 2'S'-ADP sepharose ligand affinity material two
different proteins with molecular weights of ca. 60 kDa and
25 30 kDa could be obtained. These two proteins could not be
separated by gel filtration chromatography. The specific
activity of this preparation was determined as 213 U/mg
protein.
3. N-terminal sequencing
3o N-terminal sequencing of the purified glucose-6-P
dehydrogenase was performed according to the procedure of
Edman (Edman and Begg, European Journal of Biochemistry 1,
80-91 (1967)) using a Procise~ Protein Sequencing System
(Applied Hiosystems, Foster City, USA).
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300 ,
32
For the 60 kDa protein the following N-terminal sequence
was obtained: Xaa Xaa Xaa Xaa Xaa Pro Xaa Xaa Trp Xaa Asn
Pro Leu Arg Asp. It is also shown in SEQ ID No 11.
For the 30 kDa protein the following N-terminal sequence
s was obtained: Met Ile Phe Xaa Leu Pro Asp Xaa Xaa Xaa Gln
Gln Ile Ser Lys. It is also shown in SEQ ID No 12.
Example 6
Cloning of the zwf and opcA genes into the pGEM T-vector.
PCR was used to amplify DNA fragments containing the entire
1o zwf and opcA genes of C. glutamicum ATCC13032 and flanking
upstream and downstream regions. PCR reactions were carried
out using oligonuclE.:~tide primers designed from SEQ ID NO 1
and SEQ ID NO 6. Ge.~.omic DNA was isolated from
Corynebacterium glu~ :~cnicum ATCC13032 according to l3eery and
15 Dunican (Applied and Environmental Microbiology. 59: 791-
799 (1993)) and used as template. The primers used were:
zwf fwd. primer: 5' AGA ATC AGC ACG CTG CAT CAG 3'
opcA rev. primer: 5' AGT ATG GTG CGC GTA CTA 3'
PCR parameters were as follows:
20 35 cycles
95°C for 3 minutes
94°C for 1 minute
47°C for 1 minute
72°C for 45 seconds
2s 2.5 mM MgCl2
approx. 150-200 ng DNA template.
The PCR product obtained was cloned into the commercially
available pGEM-T vector purchased from Promega Corp. (pGEM-
T Easy Vector System l, cat. no. A1360, Promega UK,
3o Southampton) using E. coli strain JM109 (Yanisch-Perron et
al., Gene 33: 103-119 (1985)) as a host.
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
33
Example 7
Preparation of the shuttle vector pEC-Tl8mob2
The E. coli - C. glutamicum shuttle vector pEC-Tl8mob2 was
constructed according to the prior art.
The vector contains the replication region rep of the
plasmid pGAl including the replication effector per (US-A-
5,175,108; Nesvera et al., Journal of Bacteriology 179,
1525-1532 (1997)), the tetracycline resistance-imparting
tetA(Z) gene of the plasmid pAGl (US-A- 5,158,891; gene
library entry at the National Center for Biotechnology
Information (NCBI, Bethesda, MD, USA) with accession number
AF121000), the replication region oriV of the plasmid pMBl
(Sutcliffe, Cold Spring Harbor Symposium on Quantitative
Biology 43, 77-90 (1979)), the lacZoc gene fragment
including the lac promoter and a multiple cloning site
(mcs) (Norrander et al. Gene 26, 101-106 (1983)) and the
mob region of the plasmid RP4 (Simon et al.,(1983)
Bio/Technology 1:784-791).
The vector constructed was transformed in the E. coli
strain DHSoc (Hanahan, In: DNA cloning. A practical
approach. Voi. I. IRL-press, Oxford, Washington DC, USA).
Selection for plasmid-carrying cells was made by plating
out the transformation batch on LB agar (Sambrook et al.,
Molecular cloning: a laboratory manual. 2"d Ed. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, N.Y.), which
had been supplemented with 5 mg/1 tetracycline. Plasmid DNA
was isolated from a transformant with the aid of the
QIAprep Spin Miniprep Kit from Qiagen and checked by
restriction with the restriction enzyme EcoRI and HindIII
3o subsequent agarose gel electrophoresis (0.8%).
The plasmid was called pEC-Tl8mob2 and is shown in
Figure 2. It is deposited in the form of the strain
Escherichia coli K-12 strain DHSa/pEC-Tl8mob2 at the
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00106300
-34
Deutsche Sammlung fur Mikroorganismen and Zellkulturen
(DSMZ = German Collection of Microorganisms and Cell
Cultures, Braunschweig, Germany) as DSM 13299.
Example 8
Expression of glucose-6-phosphate dehydrogenase in
Corynebacterium glutamicum
The entire zwf and opcA genes were subsequently isolated
from the pGEM T-vector containing these genes (see Example
6) on an SphI/SalI fragment and cloned into the lacZa
io SphI/SalI sites of the E. coli - C. glutamicum shuttle
vector pEC-Tl8mob2 (see Example 7 and Figure 2). This
shuttle vector contains two SphI sites. The first is
situated within the multiple cloning site of lacZa and the
second is situated within the gene conferring tetracycline
resistance. Tetracycline (Sigma-Aldrich, PO Box 2424,
Wimborne, Dorset BH21 7YR, UK) (5mg/1) was used therefore
as a selective pressure as only those clones containing the
intact tetracycline resistance gene would grow. This new
construct was designated pECzwfopcA (Figure 3). Restriction
2o enzyme analysis with SacI (Boehringer Mannheim GmbH,
Germany) revealed the correct orientation of the zwf and
opcA genes in the lacZa gene of pEC-Tl8mob2 i. e.
downstream the lac promotor. Corynebacterium glutamicum
ATCC13032 (American Type Culture Collection, Manasas, VA,
USA) was transformed with this construct and
electrotransformants were selected on Luria agar
supplemented with isopropyl-thiogalactopyranoside (IPTG),
5-bromo-4-chloro-3-indolyl-galactopyranoside (XGAL) and
tetracycline at concentrations of 1 mM, 0.02% and 5 mg/1
3o respectively. Agar plates were incubated for 48 hours at
30°C. Rapid plasmid preparations were carried out as
described by O~Gara and Dunican, (Applied and
Environmental Microbiology 61: 4477-4479 (1995)), and Sac I
restriction confirmed the presence of required clones. One
of the clones was designated ATCC13032/pECzwfopcA.
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
3s
Example 9
Preparation of amino acid producers with an amplified opcA
gene
The L-lysine-producing strain Corynebacterium glutamicum
DSM5715 is described in EP-H-0435132 and the L-threonine-
producing strain Brevibacterium flavum DSM5399 is described
in EP-B-0385940. Both strains are deposited at the Deutsche
Sammlung fiir Mikroorganismen and Zellkulturen [German
Collection of Microorganisms and Cell Cultures] in~
1o Braunschweig (Germany) in accordance with the Budapest
Treaty.
The strains DSM5715 and DSM5399 were transformed with the
plasmid pECzwfopcA (Example 8) using the electroporation
method described by Liebl et al., (FEMS Microbiology
Letters, 53:299-303 (1989)) Selection of the transformants
took place on LBHIS agar comprising 18.5 g/1 brain-heart
infusion broth, 0.5 M sorbitol, 5 g/1 Bacto-tryptone,
2.5 g/1 Bacto-yeast extract, 5 g/1 NaCl and 18 g/1 Bacto-
agar, which had been supplemented with 5 mg/1 tetracycline.
2o Incubation was carried out for 2 days at 33°C.
The strains obtained in this way were called
DSM5715/pECzwfopcA and DSM5399/pECzwfopcA.
Example 10
Preparation of L-threonine
The C. glutamicum strain DSM5399/pECzwfopcA obtained in
Example 9 was cultured in a nutrient medium suitable for
the production of threonine and the threonine content in
the culture supernatant was determined.
For this, the strain was first incubated on an agar plate
3o with the corresponding antibiotic (brain-heart agar with
tetracycline (5 mg/1)) for 29 hours at 33°C. Starting from
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
36
this agar plate culture, a preculture was seeded (10 ml
medium in a 100 ml conical flask). The complete medium
CgIII was used as the medium for the preculture.
Medium Cg III:
NaCl 2.5 g/1
Bacto-Peptone 10 g/1
Bacto-Yeast extract 10 g/1
Glucose (autoclaved separately) 2~ (w/v)
The pH was brought to pH 7.4.
Tetracycline (5 mg/1) was added to this. The preculture was
incubated for 16 hours at 33°C at 240 rpm on a shaking
machine. A main culture was seeded from this preculture
such that the initial OD (660nm) of the main culture Was
0.1. Medium MM was used for the main culture.
Medium MM:
CSL (corn steep liquor) 5 g/1
MOPS (morpholinopropanesulfonic 20 g/1
acid)
Glucose (autoclaved separately) 50 g/1
(NH,,)2S09 25 g/1
KH2P0, 0.1 g/1
MgS04 * 7 H20 1.0 g/1 .
CaCl2 * 2 H20 10 mg/1
FeSO,, * 7 H20 10 mg/1
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
3~
MnS04 * HZO S.Omg/1
Biotin (sterile-filtered) 0.3 mg/1
Thiamine * HC1 (sterile-filtered) 0.2 mg/1
L-Leucine (sterile-filtered) 0.1 g/1
CaC03 25 g/1
The CSL, MOPS and the salt solution were brought to pH 7
with aqueous ammonia and autoclaved. The sterile substrate
and vitamin solutions were then added, as well as the CaC03
autoclaved in the dry state.
Culturing was carried out in a 10 ml volume in a 100 ml
conical flask with baffles. Tetracycline (S mg/1) was
added. Culturing was carried out at 33°C and 80%
atmospheric humidity.
After 72 hours, the OD was determined at a measurement
wavelength of 660 nm with a Biomek 1000 (Beckmann
Instruments GmbH, Munich). The amount of threonine formed
was determined with an amino acid analyzer from Eppendorf-
BioTronik (Hamburg, Germany) by ion exchange chromatography
and post-column derivatization with ninhydrin detection.
The result of the experiment is shown in Table 1.
Table 1
Strain OD L-Threonine
g/1
DSM5399 12.3 0.74
DSM5399/pECzwfopcA 9.9 , 1.0
CA 02348365 2001-03-08
WO 01/04322 p~.~p~~~~
38
Example ll
Preparation of L-lysine
The C. glutamicum strain DSM5715/pECzwfopcA obtained in
Example 9 was cultured in a nutrient medium suitable for
the production of lysine and the lysine content in the
culture supernatant was determined.
For this, the strain was first incubated on an agar plate
with the corresponding antibiotic (brain-heart agar with
tetracycline (5 mg/1)) for 24 hours at 33°C. Starting from
i0 this agar plate culture, a preculture was seeded (10 ml
medium in a 100 ml conical flask). The complete medium
CgIII was used as the medium for the preculture.
Medium Cg III:
NaCl 2.5 g/1
Bacto-Peptone 10 g/1
Bacto-Yeast extract 10 g/1
Glucose (autoclaved separately) 2% (w/v)
The pH was brought to pH 7.4.
Tetracycline (5 mg/1) was added to this. The preculture was
incubated for 16 hours at 33°C at 240 rpm on a shaking:
machine. A main culture was seeded from this.preculture
such that the initial OD (660nm) of the-main culture was
0.1. Medium MM was used for the main culture.
CA 02348365 2001-03-08
WO 01/04322 PGT/EP00/06300
3g
Medium MM:
CSL (corn steep liquor) 5 g/1
MOPS (morpholinopropanesulfonic 20 g/1
acid)
Glucose (autoclaved separately) 58 g/1
(NH9)2509 25 g/1
KHZP09 0.1 g/1
MgS09 * 7 H2p 1.0 g/1
CaCl2 * 2 H20 10 mg/1
FeS04 * 7 H20 10 mg/1
MnS09 * H20 S.Omg/1
Biotin (sterile-filtered) 0.3 mg/1
Thiamine * HC1 (sterile-filtered) 0.2 mg/1
L-Leucine (sterile-filtered) 0.1 g/1
CaC03 25 g/1
The CSL, MOPS and the salt solution were brought to pH 7
with aqueous ammonia and autoclaved. The sterile substrate
and vitamin solutions were then added, as well as the CaC03
autoclaved in the dry state.
Culturing was carried out in a 10 ml volume in a 100 ml
conical flask with baffles. Tetracycline (5 mg/1) was
added. Culturing was carried out at 33°C and 80%
atmospheric humidity.
CA 02348365 2001-03-08
WO 01/04322 PCT/EPOOI06300
~/O
After 72 hours, the OD was determined at a measurement
wavelength of 660 nm with a Biomek 1000 (Beckmann
Instruments GmbH, Miinchen). The amount of lysine formed was
determined with an amino acid analyzer from Eppendorf-
BioTronik (Hamburg, Germany) by ion exchange chromatography
and post-column derivatization with ninhydrin detection.
The result of the experiment is shown in Table 2.
Table 2
Strain OD L-hysine HC1
g/1
DSM5715 10.8 16.0
DSM5715/pECzwfopcA 8.1 17.1
CA 02348365 2001-03-08 ,._ ___,.
WO 01/04322
PCT/EP00/06300
PCT y r
990213 BT
Original (for SUBMISSION) ~ printed on 03.07.2000 02:19:24 PM
0-1 Form - PC1IR01~34 (EASY)
Indications Relating to Deposited
Microorganisms) or Other Biological
Material (PCT Rule l3bis)
' o-1-1 Prepared using ~ pCT_~y Version 2 . 90
"" ,__ _. (updated 08 . 03 ~nnw
- .. ..Nr,~~~anrs or agent's990213 BT
tile reference
The indications made
below relate to
the deposited microorganisms)
or
other biological material
referred to In
the description on:
1-1 page
18
_ Ime 24-30
1 2
1-3 Identification of
Deposit
1-3-1 Name of depos'rtary DSO-Deutsche Sammlung VOn
insfrtution
Mikroorganismen and Zellkulturen GmbFi
132 Address ofdepos'ttary
institution
~SCheroder Weg lb, D-38124
Braunschweig, Gezatany
t-3-3 Date ofdeposa
26 January 2000 (26.01.2000)
1-3-4 Accession Number
DSMZ 13264
Additional Indications
NONE
Designated States
for Which
all designated States
Indications are Made
Separate Furnishing NONE
of Indications
These indications
will be submitted
to
the international
Bureau later
FOR RECEIVING OFFICE USE ONLY
r ms corm was received with the
international application: y a S
(yes or no)
0-4-1 Authorized officer
- C.A.,l.A. P
FOR INTERNATIONAL BUREAU USE ONLY
This form was received I
International Bureau on:
CA 02348365 2001-03-08
WO 01/04322 PCT/Ep00/06300
SEQUENCE PROTOCOL
<110> National University of Ireland, Galway
Degussa-Hills AG
Forschungszentrum Juelich GmbH
' 10
<120> New nucleotide sequences which code for the opcA gene
<130> 990213 BT
<190>
<191>
<160> 12
<170> PatentIn Ver. 2.1
<210> 1
<211> 6995
<212> DNA
<213> Corynebacterium glutamicum ATCC13032
<220>
<221> CDS
<222> (3658)..(5202)
<223> zwf
<220>
<221> CDS
<222> (5217)..(6173)
<223> opcA
<900> 1
cacatttgaaccacagttggttataaaatgggttcaacatcactatggttagaggtgttg60
acgggtcagattaagcaaagactactttcggggtagatcacctttgccaaatttgaacca120
attaacctaagtcgtagatctgatcatcggatctaacgaaaacgaaccaaaactttggtc180
90 ccggtttaacccaggaaggattgaccaccttgacgctgtcacctgaacttcaggcgctca240
ctgtacgcaattacccctctgattggtccgatgtggacaccaaggct
ta
g gacactgttc300
95 gtgtcctcgctgcagacgctgtagaaaactgtggctccggccacccaggcaccgcaatga360
gcctggctccccttgcatacaccttgtaccagcgggttatgaacgtagatccacaggaca920
ccaactgggcaggccgtgaccgcttcgttctttcttgtggccactcctctttgacccagt480
50 acatccagctttacttgggtggattcggccttgagatggatgacctgaaggctctgcgca590
cctgggattccttgaccccaggacaccctgagtaccgccacaccaagggcgttgagatca600
55 ccactggccctcttggccagggtcttgcatctgcagttggtatggccatggctgctcgtc660
gtgagcgtggcctattcgacccaaccgctgctgagggcgaatccccatt
c gaccaccaca720
tctacgtcattgcttctgatggtgacctgcaggaaggtgtcacctctgaggcatcctcca780
60 tcgctggcacccagcagctgggcaacctcatcgtgttctgggatgacaaccgcatctcca890
tcgaagacaacactgagatcgctttcaacgaggacgttgttgctcgttacaaggcttacg900
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
2
gctggcagac cattgaggtt gaggctggcg aggacgttgc agcaatcgaa gctgcagtgg 960
ctgaggctaa gaaggacacc aagcgaccta ccttcatccg cgttcgcacc atcatcggct 1020
S tcccagctcc aactatgatg aacaccggtg ctgtgcacgg tgctgctctt ggcgcagctg 1080
aggttgcagc aaccaagact gagcttggat tcgatcctga ggctcacttc gcgatcgacg 1140
atgaggttat cgctcacacc cgctccctcg cagagcgcgc tgcacagaag aaggctgcat 1200
ggcaggtcaa gttcgatgag tgggcagctg ccaaccctga gaacaaggct ctgttcgatc 1260
gcctgaactc ccgtgagctt ccagcgggct acgctgacga gctcccaaca tgggatgcag 1320
atgagaaggg cgtcgcaact cgtaaggctt ccgaggctgc acttcaggca ctgggcaaga 1380
cccttcctga gctgtggggc ggttccgctg acctcgcagg ttccaacaac accgtgatca 1990
agggctcccc ttccttcggc cctgagtcca tctccaccga gacctggtct gctgagcctt 1500
acggccgtaa cctgcacttc ggtatccgtg agcacgctat gggatccatc ctcaacggca 1560
tttccctcca cggtggcacc cgcccatacg gcggaacctt cctcatcttc tccgactaca 1620
tgcgtcctgc agttcgtctt gcagctctca tggagaccga cgcttactac gtctggaccc 1680
acgactccat cggtctgggc gaagatggcc caacccacca gcctgttgaa accttggctg 1?90
cactgcgcgc catcccaggt ctgtccgtcc tgcgtcctgc agatgcgaac gagaccgccc 1800
aggcttgggc tgcagcactt gagtacaagg aaggccctaa gggtcttgca ctgacccgcc 1860
agaacgttcc tgttctggaa ggcaccaagg agaaggctgc tgaaggcgtt cgccgcggtg 1920
gctacgtcct ggttgagggt tccaaggaaa ccccagatgt gatcctcatg ggctccggct 1980
ccgaggttca gcttgcagtt aacgctgcga aggctctgga agctgagggc gttgcagctc 2040
gcgttgtttc cgttccttgc atggattggt tccaggagca ggacgcagag tacatcgagt 2100
ccgttctgcc tgcagctgtg accgctcgtg tgtctgttga agctggcatc gcaatgcctt 2160
ggtaccgctt cttgggcacc cagggccgtg ctgtctccct tgagcacttc ggtgcttctg 2220
95 cggattacca gaccctgttt gagaagttcg gcatcaccac cgatgcagtc gtggcagcgg 2280
ccaaggactc cattaacggt taattgccct gctgttttta gcttcaaccc ggggcaatat 2390
gattctccgg aattttattg ccccgggttg ttgttgttaa tcggtacaaa gggtcttaag 2400
cacatccctt acttgcctgc tctccttgag cacagttcaa gaacaattct tttaaggaaa 2460
atttagtttc atgtctcaca ttgatgatct tgcacagctc ggcacttcca cttggctcga 2520
cgacctctcc cgcgagcgca ttacttccgg caatctcagc caggttattg aggaaaagtc 2580
tgtagtcggt gtcaccacca acccagctat tttcgcagca gcaatgtcca agggcgattc 2690
ctacgacgct cagatcgcag agctcaaggc cgctggcgca tctgttgacc aggctgttta 2700
cgccatgagc atcgacgacg ttcgcaatgc ttgtgatctg ttcaccggca tcttcgagtc 2760
ctccaacggc tacgacggcc gcgtgtccat cgaggttgac ccacgtatct ctgctgaccg 2820
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
3
cgacgcaaccctggctcagg ccaaggagct gtgggcaaaggttgatcgtccaaacgtcat2880
gatcaagatccctgcaaccc caggttcttt gccagcaatcaccgacgctttggctgaggg2990
catcagcgttaacgtcacct tgatcttctc cgttgctcgctaccgc t
a
g catcgctgc3000
gg
gttcatcgagggcatcaagc aggctgctgc aaacggccacgacgtctccaagatccactc3060
tgtggcttccttcttcgtct cccgcgtcga cgttgagatcgacaagcgcctcgaggcaat3120
cggatccgatgaggctttgg ctctgcgcgg caaggcaggcgttgccaacgctcagcgcgc3180
ttacgctgtgtacaaggagc ttttcgacgc cgccgagctgcctgaa c
t
gg caacactca3240
g
gcgcccactgtgggcatcca ccggcgtgaa gaaccctgcgtacgctgcaactctttacgt3300
ttccgagctggctggtccaa acaccgtcaa caccatgccagaaggcaccatcgacgcggt3360
tctggagcagggcaacctgc acggtgacac cctgtccaactccgc
ca
gg aagctgacgc3420
g
tgtgttctcccagcttgagg ctctgggcgt tgacttggcagatgtcttc
c aggtcctgga3980
gaccgagggtgtggacaagt tcgttgcttc ttggagcgaactgctt
a
t
g ccatggaagc3540
g
tcgcctgaagtagaatcagc acgctgcatc agtaacggcgacat
aaat
g gaattagttc3600
c
gatcttatgtggccgttaca catctttcat taaagaaaggatc
t
a
g taccatc 3657
g
cac
gtg agc aac acg acc ccc tcc agc tgg aac cca c
aca aca ctg c
V
l
g 3705
a Asn Thr Thr Pro Ser Ser Trp Asn P gac
Ser Thr Thr
ro Leu Arg Asp
1 5
10 15
ccg cag aaa cga ctc ccc cgc atc get cct tcc atg gtg
gat. ggc ggc 3753
Pro Gln
A
sp Lys Arg Leu Pro Arg Ile Ala Pro Ser Met Val
Gly Gly
20 25 30
atc ttc gtc act ggc gac ttg get cga aag ctg ccc
ggt aag ctc
Il
gcc 3801
e Phe Gly Val Thr Gly Asp Leu Ala Arg Lys Leu
Lys L
eu Pro Ala
35 40
45
att tat cta gca aac cgc gga ttg ctg tcg ttg
gat ccc cca gga ttc 3899
Ile T
r A
y Leu Ala Asn Arg Gly Leu Leu Ser L
sp Pro Pro Gly Phe
eu
95 50 55 60
gta ggt ggc cgc cgc gaa tgg tcc aaa
tac gaa gac ttt
gaa aaa tac 897
Val Gly Gly Arg Arg Glu Trp Ser Lys 3
Tyr Glu As
Phe Gl
p Lys Tyr
65 70 u
75 80
CA 02348365 2001-03-08
WO 01/04322 pC1'/Ep00/06300
4
gta cgc gat gcc gca agt get ggt get cgt acg gaa ttc cgt gaa aat 3995
Val Arg Asp Ala Ala Ser Ala Gly Ala Arg Thr Glu Phe Arg Glu Asn
85 90 95
. gtt tgg gag cgc ctc gcc gag ggt atg gaa ttt gtt cgc ggc aac ttt 3993
Val Trp Glu Arg Leu Ala Glu Gly Met Glu Phe Val Arg Gly Asn Phe
100 105 110
gat gat gat gca get ttc gac aac ctc get gca aca ctc aag cgc atc 9041
Asp Asp Asp Ala Ala Phe Asp Asn Leu Ala Ala Thr Leu Lys Arg Ile
115 120 125
gac aaa acc cgc ggc acc gcc ggc aac tgg get tac tac ctg tcc att 9089
Asp Lys Thr Arg Gly Thr Ala Gly Asn Trp Ala Tyr Tyr Leu Ser Ile
130 135 190
cca ccagat tccttc acagcggtc tgccac cagctg cgttcc
P gag
ggc 9137
ro ProAsp SerPhe ThrAlaVal CysHis GlnLeu A
Gl
u rg Ser Gly
195 150
155 160
atg getgaa tccacc gaagaagca tggcgc cgcgtgatc atca
g aag 9185
Met AlaGlu SerThr GluGluAla TrpArg ArgValIl Il g
e e Glu Lys
165
170 175
cct ttcggc cacaac ctcgaatcc gcacac gagctcaac cagctg gtc 4233
Pr Ph
o e Gly HisAsn LeuGluSer AlaHis GluLeuAsn GlnL V
eu al
180 185
190
aac gcagtc ttccca gaatcttct gtgttc cgcatcac
g cactat ttg 9281
Asn AlaVal PhePro GluSerSer ValPh A
e rg IleAsp HisTyr Leu
195
200 205
ggc aaggaa acagtt caaaacatc ctgget ctgcgtttt getaac cag 4329
Gl L Gl
y ys u ThrVal GlnAsnIle LeuAla LeuArgPhe AlaAsn Gl
n
210 215 220
ctg tttgag ccactg tggaactcc aactac gttgaccac gtcca t 937
g a 7
Leu PheGlu ProLeu TrpAsnSer AsnTyr ValAs His V c
l
p a Gln Ile
225 230
235 240
acc atgget gaagat attggcttg ggtgga cgtgetggt tact
ac gac 4425
Thr MetAla GluAsp IleGlyLeu GlyGly ArgAlaGl T T
y yr yr Asp
245
250 255
ggc atcggc gcagcc cgcgacgtc atccag aaccacctg atccag ctc 9973
Gl Il Gl
y e y AlaAla ArgAspVal IleGln AsnHisLeu IleGln Leu
260 265 270
ttg getctg gttgcc atggaagaa ccaatt tctttcgtg ccac
g cag 9521
Leu AlaLeu ValAla MetGluGlu ProIle SerPh g
e Val ProAla Gln
275
280 285
ctg caggca gaaaag atcaaggtg ctctct gcg aag ccgtgc 9569
Leu Gl aca tac
n Ala GluLys IleLysVal LeuSer Ala Lys Pro
290 Thr Cys
T
r
295 300 y
CA 02348365 2001-03-08
WO 01/04322
PCT/EP00/06300
s
cca ttg gat aaa acc tcc get cgt ggt ca
t
g 9617
ac get gcc ggt tgg cag
Pro Leu Asp Lys Thr Ser Ala Arg Gl
Gl
y
305
n Tyr Ala Ala Gly Trp Gln
310
315 320
ggc tct gag tta gtc aa~g gga ctt cgc
aa
g 9665
gaa gat ggc ttc aac cct
Gly Ser Glu Leu Val Lys Gly Leu Ar
Gl
g
u Glu Asp Gly Phe Asn Pro
325
330
335
gag tcc acc act gag act ttt gcg get tgt ac
t
c 9713
ta gag atc acg tct
Glu Ser Thr Thr Glu Thr Phe Ala Al
a Cys Thr Leu Glu Ile Thr Ser
390
395
350
cgt cgc tgg get ggt gtg ccg ttc tac ctg c
c
A
g 9761
acc ggt aag cgt ctt
rg Arg Trp Ala Gly Val Pro Phe T
r L
y
eu Arg Thr Gly Lys Arg Leu
355
360
365
ggt cgc cgt gtt act gag att gcc gtg gtg ttt
Gl
aaa gac gca cca cac 4809
y Arg Arg Val Thr Glu Ile Ala Val V
l
a
Phe Lys Asp Ala Pro His
370 375
380
cag cct ttc gac ggc gac atg act gta tcc ctt
ggc caa aac gcc atc 9857
Gln Pro Phe Asp Gly Asp Met Thr Val S
385
er Leu Gly Gln Asn Ala Ile
390
395 400 '
gtg att cgc gtg cag cct gat gaa ggt gtg ctc atc
V
l
9905
a
cgc ttc ggt tcc
Ile Arg Val Gln Pro Asp Glu Gl
Val L
y
eu Ile Arg Phe Gly Ser
405
410
415
aag gtt cca ggt tct gcc atg gaa gtc cgt
a
g 9953
c gtc aac atg gac ttc
Lys Val Pro Gly Ser Ala Met Glu V
l
a
Arg Asp Val Asn Met Asp Phe
420
425
430
tcc tac tca gaa tcc ttc act gaa gaa tca cct
gaa gca tac gag cgc 5001
Ser Tyr Ser Glu Ser Phe Thr Glu Glu Se
P
r
ro Glu Ala Tyr Glu Arg
935
440
445
ctc~att ttg gat gcg ctg tta gat gaa tcc
agc ctc ttc cct acc aac 5099
Leu Ile Leu Asp Ala Leu Leu Asp Gl
S
u
er Ser Leu Phe Pro Thr Asn
450
455
9 60
gag 9aa gtg gaa ctg agc tgg aag att ctg gat cca
Gl
t
a 5097
t ctt gaa gca
u Glu Val Glu Leu Ser Trp Lys Ile L
965
eu Asp pro Ile Leu Glu Ala
970
975 980
tg9 Sat gcc gat gga gaa cca gag gat tac
cca gcg ggt acg tgg ggt 5195
Trp Asp Ala Asp Gly Glu Pro Glu As
T
p
yr Pro Ala Gly Thr Trp Gly
985
990
9 95
cca aag agc get gat gaa atg ctt tcc
cgc aac ggt cac acc tgg cgc 5193
Pro Lys Ser Ala Asp Glu Met Leu S
er Arg Asn Gly His Thr Trp Arg
500
505
510
agg cca taa tttaggggca aaaa atg atc ttt
gaa ctt ccg gat acc acc 5243
Arg Pro Met Il
e Phe Glu Leu Pro Asp Thr Thr
515
520
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
6
acc cag caa att tcc aag acc cta act cga ctg cgt gaa tcg ggc acc 5291
Thr Gln Gln Ile Ser Lys Thr Leu Thr Arg Leu Arg Glu Ser Gly Thr
525
530 535 590
~ cag gtc acc acc ggc cga gtg ctc acc ctc atc gtg gtc act gac tcc 5339
Gln Val Thr Thr Gly Arg Val Leu Thr Leu Ile Val Val Thr Asp Ser
595 550 555
~ 10 gaa agc gat gtc get gca gtt acc gag tcc acc aat gaa gcc tcg cgc 5387
Glu Ser Asp Val Ala Ala Val Thr Glu Ser Thr Asn Glu Ala Ser Arg
560 565 5?0
gag cac cca ct cgc gtg atc att ttg gtg gtt ggc gat aaa act gca 5435
Glu His Pro Ser Arg Val Ile Ile Leu Val Val Gly Asp Lys Thr Ala
575 580 585
gaa aac aaa gtt gac gca gaa gtc cgt atc ggt ggc gac get ggt get 5483
Glu Asn Lys Val Asp Ala Glu Val Arg Ile Gly Gly Asp Ala Gly Ala
590 595 600
tcc gag atg atc atc atg cat ctc aac gga cct gtc get gac aag ctc 5531
Ser Glu Met Ile Ile Met His Leu Asn Gly Pro Val Ala Asp Lys Leu
605
610 615 620
cag tat gtc gtc aca cca ctg ttg ctt cct gac acc ccc atc gtt get 5579
Gla Tyr Val Val Thr Pro Leu Leu Leu Pro Asp Thr Pro Ile Val Ala
625 630 635
tgg tgg cca ggt gaa tca cca aag aat cct tcc cag gac cca att gga 5627
Trp Trp Pro Gly Glu Ser Pro Lys Asn Pro Ser Gln Asp Pro Ile Gly
640 695 650
cgc atc gca caa cga cgc atc act gat get ttg tac gac cgt gat gac 5675
Arg Ile Ala Gln Arg Arg Ile Thr Asp Ala Leu Tyr Asp Arg Asp Asp
655 660 665
gca cta gaa gat cgt gtt gag aac tat cac cca ggt gat acc gac atg 5723
Ala Leu Glu Asp Arg Val Glu Asn Tyr His Pro 680y Asp Thr Asp Met
670 675
acg tgg gcg cgc ctt acc cag tgg cgg gga ctt gtt gcc tcc tca ttg 5771
Thr Trp Ala Arg Leu Thr Gln Trp Arg Gly Leu Val Ala Ser Ser Leu
685
95 690 695 700
gat cac cca cca cac agc gaa atc act tcc gtg agg ctg acc ggt gca 5819
Asp His Pro Pro His Ser Glu Ile Thr Ser Val Arg Leu Thr Gly Ala
705 710 715
agc ggc agt acc tcg gtg gat ttg get gca ggc tgg ttg gcg cgg agg 5867
Ser Gly Ser Thr Ser Val Asp Leu Ala Ala Gly Trp Leu Ala Arg Arg
720 725 730
ctg aaa gtg cct gtg atc cgc gag gtg aca gat get ccc acc gtg cca 5915
Leu Lys Val Pro Val Ile Arg Glu Val Thr Asp Ala Pro Thr Val Pro
735 790 795
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
acc gat gagttt ggtactcca ctgctg getatc cagcgc ctggagatc 5963
Thr Asp GluPhe GlyThrPro LeuLeu AlaIle GlnArg LeuGluIle
750 755 760
gtt cgc accacc ggctcgatc atcatc accatc tatgac getcatacc 6011
Val Arg ThrThr GlySerIle IleIle ThrIle TyrAsp AlaHisThr
765 770 775
780
ctt cag gtagag atgccggaa tccggc aatgcc ccatcg ctggtgget 6059
Leu Gln ValGlu MetProGlu SerGly AsnAla ProSer LeuValAla
785 790 795
att ggt cgtcga agtgagtcc gactgc ttgtct gaggag cttcgccac 6107
Ile Gly ArgArg SerGluSer AspCys LeuSer GluGlu LeuArgHis
800 . 805 810
atg gat cca gat ttg ggc tac cag cac gca cta tcc ggc ttg tcc agc 6155
Met Asp Pro Asp Leu Gly Tyr Gln His Ala Leu Ser Gly Leu Ser Ser
815 820 825
gtc aag 6203
ctg gaa
acc gtc
taaggagaaa
tacaacacta
tggttgatgt
Val Lys
Leu Glu
Thr Val
830
agtacgcgca cgcgatactgaagatttggttgcacaggctgcctccaaattcattgaggt6263
tgttgaagca gcaactgccaataatggcaccgcacaggtagtgctcaccggtggtggcgc6323
cggcatcaag ttgctggaaaagctcagcgttgatgcggctgaccttgcctgggatcgcat6383
tcatgtgttc ttcggcgatgagcgcaatgtccctgtcagtgattctgagtccaatgaggg6443
ccaggctcgt gaggcactgttgtccaaggtttctatccctgaagccaacattcacggata6503
tggtctcggc gacgtagatcttgcagaggcagcccgcgcttacgaagctgtgttggatga6563
attcgcacca aacggctttgatcttcacctgctcggcatgggtggcgaaggccatatcaa6623
ctccctgttc cctcacaccgatgcagtcaaggaatcctccgcaaaggtcatcgcggtgtt6683
tgattcccct aagcctccttcagagcgtgcaactctaacccttcctgcggttcactccgc6743
q5 aaagcgcgtg tggttgctggtttctggtgcggagaaggctgaggcagctgcggcgatcgt6803
caacggtgag cctgctgttgagtggcctgctgctggagctaccggatctgaggaaacggt6863
attgttcttg gctgatgatgctgcaggaaatctctaagcagcgccagctctaacaagaag6923
ctttaacaag aagctctaacgaaaagcactaacaaactaatccgggtgcgaaccttcatc6983
tgaatcgatg ga
6995
<210> 2
<211> 514
<212> PRT
<213> Corynebacterium glutamicum ATCC13032
<400> 2
Val Ser Thr Asn Thr Thr Pro Ser Ser Trp Thr Asn Pro Leu Arg Asp
1 5 10 15
CA 02348365 2001-03-08
WO O1/043Z2 PCT/EP00/06300
8
Pro GlnAsp ArgLeu ProArg IleAla Gly
Lys 25 Pro.Ser
20 Gly
Met
Val
30
Ile PheGly ThrGly AspLeu AlaArg Lys
Val 90 Lys
35 Leu
Leu
Pro
Ala
95
Ile TyrAsp AlaAsn ArgGly LeuLeu Pro
50 Leu 55 Pro
Gly
Phe
Ser
Leu
60
' 10 Val GlyTyr ArgArg GluTrp SerLys Glu Glu Lys
65 Gly 70 Asp Tyr
Phe 80
75
Val ArgAsp AlaSer AlaGly AlaArg ThrGlu Arg Glu
Ala 85 90 Phe Asn
95
Val TrpGlu LeuAla GluGly MetGlu PheVal Gly Asn
Arg 105 Arg Phe
100 110
Asp AspAsp AlaPhe AspAsn LeuAla AlaThr Lys Arg
Ala 120 Leu Ile
115
125
Asp LysThr GlyThr AlaGly AsnTrp AlaTyr Leu Ser
130Arg 135 Tyr Ile
190
Pro ProAsp PheThr AlaVal CysHis GlnLeu Arg Ser
195 Ser 150 155Glu Gly
160
Met AlaGlu ThrGlu GluAla TrpArg ArgVal Ile Glu
Ser 165 170 Ile Lys
175
Pro PheGly AsnLeu GluSer AlaHis GluLeu Gln Leu
His 185 Asn Val
180 190
Asn AlaVal ProGlu SerSer ValPhe ArgIle His Tyr
Phe 200 Asp Leu
195
205
Gly LysGlu ValGln AsnIle LeuAla LeuArg Ala Asn
210Thr 215 Phe Gln
220
90 Leu PheGlu LeuTrp AsnSer AsnTyr ValAsp Val Gln
225 Pro 230 235His Ile
240
Thr MetAla AspIle GlyLeu GlyGly Ala Tyr Tyr
Glu 245 Arg Gly Asp
250 255
Gly IleGly AlaArg AspVal IleGln His Ile Gln
Ala 265Asn Leu Leu
260 270
Leu Leu Met GluGlu ProIle Phe Pro Ala
Ala Val 280 Ser Val Gln
Ala
275 285
Leu Ile Thr Pro Cys
Gln Lys Lys Tyr
Ala Val 300
Glu Leu
Lys Ser
290 Ala
295
CA 02348365 2001-03-08
WO 01/04322 PC'T/EP00/06300
9
Pro Leu Asp Lys Thr Ser Ala Arg Gly Gln Tyr Ala Ala Gly Trp Gln
305 310 315
320
Gly Ser Glu Leu Val Lys Gly Leu Arg Glu Glu Asp Gly Phe Asn Pro
325 ~ 330 335
Glu Ser Thr Thr Glu Thr Phe Ala Ala Cys Thr Leu Glu Ile Thr Ser
340 395 350
' 10
Arg Arg Trp Ala Gly Val Pro Phe Tyr Leu Arg Thr Gly Lys Arg Leu
355 360 365
Gly Arg Arg Val Thr Glu Ile Ala Val Val Phe Lys Asp Ala Pro His
370 375 380
Gln Pro Phe Asp Gly Asp Met Thr Val Ser Leu Gly Gln Asn Ala Ile
385 390 395
900
Val Ile Arg Val Gln Pro Asp Glu Gly Val Leu Ile Arg Phe Gly Ser
405 910 915
Lys Val Pro Gly Ser Ala Met Glu Val Arg Asp Val Asn Met Asp Phe
920 925 930
Ser Tyr Ser Glu Ser Phe Thr Glu Glu Ser Pro Glu Ala Tyr Glu Arg
935 940 945
Leu Ile Leu Asp Ala Leu Leu Asp Glu Ser Ser Leu Phe Pro Thr Asn
950 455 460
Glu Glu Val Glu Leu Ser Trp Lys Ile Leu Asp Pro Ile Leu Glu Ala
965 970 975
480
Trp Asp Ala Asp Gly Glu Pro Glu Asp Tyr Pro Ala Gly Thr Trp Gly
485 490 995
Pro Lys Ser Ala Asp Glu Met Leu Ser Arg Asn Gly His Thr Trp Arg
500 505 510
Arg Pro
<210> 3
95 <211> 319
<212> PRT
<213> Corynebacterium
glutamicum
ATCC13032
<900> 3
Met Ile Glu LeuPro Asp Thr Thr Gln IleS
Phe Thr Gln
er Lys Thr
1 5
10 15
Leu Thr Arg Leu ArgGlu Ser Thr Gln Val ThrGly Arg
Gly Thr Val
20 25 30
Leu Thr Leu Ile ValVal Thr Ser Glu Ser ValAla Al
Asp Asp V
a
35 90 al
95
Thr Glu Ser Thr Asn Glu Ala Ser Arg Glu His Pro Ser Arg Val ile
50 55 60
Ile Leu Val Val Gly Asp Lys Thr Ala Glu Asn Lys Val Asp Ala Glu
CA 02348365 2001-03-08
WO 01/043ZZ PCT/EP00/06300
/D
65 70 75 80
Val Arg Ile Gly Gly Asp Ala Gly Ala Ser Glu Met Ile Ile Met His
85 90 95
Leu Asn Gly Pro Val Ala~Asp Lys Leu Gln Tyr Val Val Thr Pro Leu
100 105
110
Leu Leu Pro Asp Thr Pro Ile Val Ala Trp Trp Pro Gly Glu Ser Pro
' 10 115 120
125
Lys Asn Pro Ser Gln Asp Pro Ile Gly Arg Ile Ala Gln Arg Arg Ile
130 135
190
Thr Asp Ala Leu Tyr Asp Arg Asp Asp Ala Leu Glu Asp Arg Val Glu
195 150
155 160
Asn Tyr His Pro Gly Asp Thr Asp Met Thr Trp Ala Arg Leu Thr Gln
165 170 175
Trp Arg Gly Leu Val Ala Ser Ser Leu Asp His Pro Pro His Ser Glu
180 185
190
Ile Thr Ser Val Arg Leu Thr Gly Ala Ser Gly Ser Thr Ser Val Asp
195 200
205
Leu Ala Ala Gly Trp Leu Ala Arg Arg Leu Lys Val Pro Val Ile Arg
210 215
220
Glu Val Thr Asp Ala Pro Thr Val Pro Thr Asp Glu Phe Gly Thr Pro
225 230
235 290
Leu Leu Ala Ile Gln Arg Leu Giu Ile Val Arg Thr Thr Gly Ser Ile
245 250 255
Ile Ile Thr Ile Tyr Asp Ala His Thr Leu Gln Val Glu Met Pro Glu
260 265 270
Ser Gly Asn Ala Pro Ser Leu Val Ala Ile Gly Arg Arg Ser Glu Ser
90 275 280
285
Asp Cys Leu Ser Glu Glu Leu Arg His Met Asp Pro Asp Leu Gly Tyr
290 295
300
95 Gln His Ala Leu Ser Gly Leu Ser Ser Val Lys Leu Glu Thr Val
305 310
315
50 <210> 9
<211> 960
<212> DNA
<213> Corynebacterium glutamicum ATCC13032
55 <220>
<221> CDS
<222> (1)..(957)
<223> opcA
60 <900> 4
atg atc ttt gaa ctt ccg gat acc acc acc cag caa att tcc aag acc 98
Met Ile Phe Glu Leu Pro Asp Thr Thr Thr Gln Gln Ile Ser Lys Thr
1 5 10 15
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
1
cta act cga ctg cgt gaa tcg ggc acc cag gtc acc acc ggc cga gtg 96
Leu Thr Arg Leu Arg Glu Ser Gly Thr Gln Val Thr Thr Gly Arg Val
20 25 30
ctc acc ctc atc gtg gtc act gac tcc gaa agc gat gtc get gca gtt 199
Leu Thr Leu Ile Val Val Thr Asp Ser Glu Ser Asp Val Ala Ala Val
35 90 45
' 10 acc gag tcc acc aat gaa gcc tcg cgc gag cac cca tct cgc gtg atc 192
Thr Glu Ser Thr Asn Glu Ala Ser Arg Glu His Pro Ser Arg Val Ile
50 55 60
att ttg gtg gtt ggc gat aaa act gca gaa aac aaa gtt gac gca gaa 290
Ile Leu Val Val Gly Asp Lys Thr Ala Glu Asn Lys Val Asp Ala Glu
65 70 75 80
gtc cgt atc ggt ggc gac get ggt get tcc gag atg atc atc atg cat 288
Val Arg Ile Gly Gly Asp Ala Gly Ala Ser Glu Met Ile Ile Met His
85 90 95 .
ctc aac gga cct gtc get gac aag ctc cag tat gtc gtc aca cca ctg 336
Leu Asn Gly Pro Val Ala Asp Lys Leu Gln Tyr Val Val Thr Pro Leu
100 105 110
ttg ctt cct gac acc ccc atc gtt get tgg tgg cca ggt gaa tca cca 389
Leu Leu Pro Asp Thr Pro Ile Val Ala Trp Trp Pro Gly Glu Ser Pro
i15 120 125
aag aat cct tcc cag gac cca att gga cgc atc gca caa cga cgc atc 432
Lys Asn Pro Ser Gln Asp Pro Ile Gly Arg Ile Ala Gln Arg Arg Ile
130 135 190
act gat get ttg tac gac cgt gat gac gca cta gaa gat cgt gtt gag 980
Thr Asp Ala Leu Tyr Asp Arg Asp Asp Ala Leu Glu Asp Arg Val Glu
145 150 155
160
aac tat cac cca ggt gat acc gac atg acg tgg gcg cgc ctt acc cag 528
Asn Tyr His Pro i65 Asp Thr Asp Met Thr Trp Ala Arg Leu Thr Gln
q.0 170
175
tgg cg9 gga ctt gtt gcc tcc tca ttg gat cac cca cca cac agc gaa 576
Trp Arg Gly Leu Val Ala Ser Ser Leu Asp His Pro Pro His Ser Glu
180 185 190
atc act tcc gtg agg ctg acc ggt gca agc ggc agt acc tcg gtg gat 629
Ile Thr Ser Val Arg Leu Thr Gly Ala Ser Gly Ser Thr Ser Val Asp
195 200 205
CA 02348365 2001-03-08
WO 01/04322
PCT/EP00/06300
12
ttg get gca ggc tgg ttg gcg cgg agg ctg aaa gtg cct gtg atc cgc 672
Leu Ala Ala Gly Trp Leu Ala Arg Arg Leu Lys Val Pro Val Ile Arg
210
215 220
gag gtg acagatget cccacc gtgcca accgata t
g tt ggt actcca 720
Glu Val ThrAspAla ProThr ValP g
ro ThrAspGlu PheGly ThrPro
225 230
235 240
' 10 ctg ctg getatccag cgcctg gagatc gttc
c
g acc accggc tcgatc 768
Leu Leu AlaIleGln ArgLeu GluIl V
e al ArgThr ThrGly SerIle
295
250
255
atc atc accatctat gacget catacc cttcaggta a
Il
g atg ccggaa 816
e Ile ThrIleTyr AspAla HisThr LeuGl V g
n al GluMet ProGlu
260
265
270
tcc ggc aatgcccca tcgctg gtgget attggtc
t
g cgaagt gagtcc 864
Ser Gly AsnAlaPro SerLeu ValAl
a IleGlyArg ArgSer GluSer
275
280
285
gac tgc ttgtctgag gagctt cgccac atggatcca t
A
ga ttg ggctac 912
sp Cys LeuSerGlu GluLeu Ar His M
g et AspPro AspLeu GlyTyr
290
295 300
cag cac gcactatcc ggcttg tccagc gtcaagctg aa
Gl
g acc gtctaa 960
n His AlaLeuSer GlyLeu SerSer V
l
a LysLeu GluThr Val
305 310
315
<210> 5
<211> 319
<212> PRT
<213> Corynebacterium glutamicum ATCC13032
<400> 5
Met Ile Phe Glu Leu Pro Asp Thr Thr Thr Gln Gln Ile Ser Lys Thr
1 5 10 15
90 Leu Thr Arg Leu Arg Glu Ser Gly Thr Gln Val Thr Thr Gly Arg Val
20 25 30
Leu Thr Leu Ile Val Val Thr Asp Ser Glu Ser Asp Val Ala Ala Val
35 40 45
Thr Glu Ser Thr Asn Glu Ala Ser Arg Glu His Pro Ser Arg Val Ile
55 60
Ile Leu Val Val Gly Asp Lys Thr Ala Glu Asn Lys Val Asp Ala Glu
50 65 70 75 80
Val Arg Ile Gly Gly Asp Ala Gly Ala Ser Glu Met Ile Ile Met His
85 90 95
Leu Asn Gly Pro Val Ala Asp Lys Leu Gln Tyr Val Val Thr Pro Leu
100 105
110
Leu Leu Pro Asp Thr Pro Ile Val Ala Trp Trp Pro Gly Glu Ser Pro
115 120 125
Lys Asn Pro Ser Gln Asp Pro Ile Gly Arg Ile Ala Gln Arg Arg Ile
130 135
190
CA 02348365 2001-03-08
WO Ol/04322 PCT/EP00/06300
t3
Thr AspAla LeuTyrAsp ArgAsp AspAlaLeu GluAspArg Val Glu
195 150 155
160
Asn TyrHis ProGlyAsp ThrAsp MetThrTrp AlaArgLeu Thr Gln
165 170
175
Trp ArgGly LeuValAla SerSer LeuAspHis ProProHis Ser Glu
180 185 190
Ile ThrSer ValArgLeu ThrGly AlaSerGly SerThrSer Val Asp
195 200 205
Leu AlaAla GlyTrpLeu AlaArg ArgLeuLys ValProVal Ile Arg
210 215 220
Glu ValThr AspAlaPro ThrVal ProThrAsp GluPheGly Thr Pro
225 230 235
240
Leu LeuAla IleGlnArg LeuGlu IleValArg ThrThrGly Ser Ile
245 250 255
Ile IleThr IleTyrAsp AlaHis ThrLeuGln ValGluMet Pro Glu
260 265 270
Ser GlyAsn AlaProSer LeuVal AlaIleGly ArgArgSer Glu Ser
275 280 285
Asp CysLeu SerGluGlu LeuArg HisMetAsp ProAspLeu Gly Tyr
290 295 300
Gln HisAla LeuSerGly LeuSer SerValLys LeuGluThr Val
305 310 315
<210> 6
<211> 3038
<212> DNA
<213> Corynebacterium glutamicum
AS019
<220>
<221> CDS
<222> (115)..(1659)
<223> zwf
<220>
<221> CDS
<222> (1672)..(2628)
<223> opcA
<400> 6
cctgaagtag aatcagcacg ctgcatcagt aacggcgaca tgaaatcgaa ttagttcgat 60
CA 02348365 2001-03-08
WO 01 /04322 PCT/EP00/06300
!y
cttatgtggc cgttacacat ctttcattaa agaaaggatc gtgacactac catc gtg 117
Val
1
agc aca aac acg acc ccc tcc agc tgg aca aac cca ctg cgc gac ccg 165
Ser Thr Asn Thr Thr Pro Ser Ser Trp Thr Asn Pro Leu Arg Asp Pro
5 10 15
cag gat aaa cga ctc ccc cgc atc get ggc cct tcc ggc atg gtg atc 213
Gln Asp Lys Arg Leu Pro Arg Ile Ala Gly Pro Ser Gly Met Val Ile
25 30
ttc ggt gtc act ggc gac ttg get cga aag aag ctg ctc ccc gcc att 261
Phe Gly Val Thr Gly Asp Leu Ala Arg Lys Lys Leu Leu Pro Ala Ile
15 35 90 95
tat gat cta gca aac cgc gga ttg ctg ccc cca gga ttc tcg ttg gta 309
Tyr Asp Leu Ala Asn Arg Gly Leu Leu Pro Pro Gly Phe Ser~Leu Val
20 55 60 65
ggt tac ggc cgc cgc gaa tgg tcc aaa gaa gac ttt gaa aaa tac gta 357
Gly Tyr Gly Arg Arg Glu Trp Ser Lys Glu Asp Phe Glu Lys Tyr Val
70 75 80
25 cgc gat gcc gca agt get ggt get cgt acg gaa ttc cgt gaa aat gtt 405
Arg Asp Ala Ala Ser Ala Gly Ala Arg Thr Glu Phe Arg Glu Asn Val
85 90 95
t9g gag cgc ctc gcc gag ggt atg gaa ttt gtt cgc ggc aac ttt gat 453
30 Trp Glu Arg Leu Ala Glu Gly Met Glu Phe Val Arg Gly Asn Phe Asp
100 105 110
gat gat gca get ttc gac aac ctc get gca aca ctc aag cgc atc gac 501
Asp Asp Ala Ala Phe Asp Asn Leu Ala Ala Thr Leu Lys Arg Ile Asp
35 115 120
125
aaa acc cgc ggc acc gcc ggc aac tgg get tac tac ctg tcc att cca 549
Lys Thr Arg Gly Thr Ala Gly Asn Trp Ala Tyr Tyr Leu Ser Ile Pro
130
40 135 140 145
cca gat tcc ttc aca gcg gtc tgc cac cag ctg gag cgt tcc ggc atg 597
Pro Asp Ser Phe Thr Ala Val Cys His Gln Leu Glu Arg Ser Gly Met
150 155 160
45 get gaa tcc acc gaa gaa gca tgg cgc cgc gtg atc atc gag aag cct 645
Ala Glu Ser Thr Glu Glu Ala Trp Arg Arg Val Ile Ile Glu Lys Pro
165 170 175
ttc ggc cac aac ctc gaa tcc gca cac gag ctc aac cag ctg gtc aac 693
50 Phe Gly His Asn Leu Glu Ser Ala His Glu Leu Asn Gln Leu Val Asn
180 185 190
gca gtc ttc cca gaa tct tct gtg ttc cgc atc gac cac tat ttg ggc 741
Ala Val Phe Pro Glu Ser Ser Val Phe Arg Ile Asp His Tyr Leu Gly
195 200 205
aag gaa aca gtt caa aac atc ctg get ctg cgt ttt get aac cag ctg 789
210 Glu Thr Val Gln Asn Ile Leu Ala Leu Arg Phe Ala Asn Gln Leu
215 220 225
ttt gag cca ctg tgg aac tcc aac tac gtt gac cac gtc cag atc acc 837
Phe Glu Pro Leu Trp Asn Ser Asn Tyr Val Asp His Val Gln Ile Thr
230 235 240
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
is
atg get gaa gat att ggc ttg ggt gga cgt get ggt tac tac gac ggc 885
Met Ala Glu Asp Ile Gly Leu Gly Gly Arg Ala Gly Tyr Tyr Asp Gly
245 250 255
atc ggc gca ccg cgc gac gtc atc cag aac cac ctg atc cag ctc ttg 933
Ile Gly Ala Pro Arg Asp Val Ile Gln Asn His Leu Ile Gln Leu Leu
260 265 270
get ctg gtt gcc atg gaa gaa cca att tct ttc gtg cca gcg gca cgg 981
Ala Leu Val Ala Met Glu Glu Pro Ile Ser Phe Val Pro Ala Ala Arg
275 280 285
cag gcagaa aagatc aaggtg ctctct gcgaca aagccgtgc taccca 1029
Gln AlaGlu LysIle LysVal LeuSer AlaThr LysProCys TyrPro
290 295 300 305
ttg gataaa acctcc getcgt ggtcag tacget gccggttgg cagggc 1077
Leu AspLys ThrSer AlaArg GlyGln TyrAla AlaGlyTrp GlnGly
310 315 320
tct gagtta gtcaag ggactt cgcgaa gaagat ggcttcaac cctgag 1125
Ser GluLeu ValLys GlyLeu ArgGlu GluAsp GlyPheAsn ProGlu
325 330 335
tcc accact gagact tttgcg gettgt acctta gagatcacg tctcgt 1173
Ser ThrThr GluThr PheAla AlaCys ThrLeu GluIleThr SerArg
390 345 350
cgc tggget ggtgtg ccgttc tacctg cgcacc ggtaagcgt cttggt 1221
Arg TrpAla GlyVal ProPhe TyrLeu ArgThr GlyLysArg LeuGly
355 360 365
cgc cgt gtt act gag att gcc gtg gtg ttt aaa gac gca cca cac cag 1269
Arg Arg Val Thr Glu Ile Ala Val Val Phe Lys Asp Ala Pro His Gln
370 375 380 385
cct ttc gac ggc gac atg act gta tcc ctt ggc caa aac gcc atc gtg 1317
Pro Phe Asp Gly Asp Met Thr Val Ser Leu Gly Gln Asn Ala Ile Val
390 395 400
att cgc gtg cag cct gat gaa ggt gtg ctc atc cgc ttc ggt tcc aag 1365
Ile Arg Val Gln Pro Asp Glu Gly Val Leu Ile Arg Phe Gly Ser Lys
905 410 915
gtt cca ggt tct gcc atg gaa gtc cgt gac gtc aac atg gac ttc tcc 1913
Val Pro Gly Ser Ala Met Glu Val Arg Asp Val Asn Met Asp Phe Ser
920 425 930
tac tca gaa tcc ttc act gaa gaa tca cct gaa gca tac gag cgc ctc 1961
Tyr Ser Glu Ser Phe Thr Glu Glu Ser Pro Glu Ala Tyr Glu Arg Leu
935 440 445
CA 02348365 2001-03-08
WO 01/04322
PCT/EP00/06300
att ttg gat gcg ctg tta gat gaa tcc
agc ctc ttc cct acc aac gag 1509
Ile Leu Asp Ala Leu Leu Asp Gl
S
u
er Ser Leu Phe Pro Thr Asn Glu
950
955
460 965
. gaa gtg gaa ctg agc tgg aag att ctg gat cca
t
a 1557
t ctt gaa gca tgg
Glu Val Glu Leu Ser Trp Lys Ile L
eu Asp Pro Ile Leu Glu Ala Trp
970
975
980
' 10 gat gcc gat gga gaa cca gag gat tac cc
a gcg ggt acg tgg ggt cca 1605
Asp Ala Asp Gly Glu Pro Glu Asp T
r p
y
ro Ala Gly Thr Trp Gly Pro
985
990
995
aag agc get gat gaa atg ctt tcc cgc aac ggt cac ac
L
s S
t
1653
y
c
gg cgc agg
er Ala Asp Glu Met Leu Ser Arg Asn Gl
y His Thr Trp Arg Arg
500
505
510
cca taa tttaggggca as atg atc ttt
gaa ctt ccg gat acc acc acc ca g 1704
Pro Met Ile Ph
e Glu Leu Pro Asp Thr Thr Thr Gln
515
520 525
caa att tcc aag acc cta act cga ctg cgt
aa t
g 1752
cg ggc acc cag gtc
Gln Ile Ser Lys Thr Leu Thr Ar
Le
A
g
u
rg Glu Ser Gly Thr Gln Val
530
535
590
acc acc ggc cga gtg ctc acc.ctc atc gtg gtc a
t
Th
c 1800
gac tcc gaa agc
r Thr Gly Arg Val Leu Thr Leu Il
e Val Val Thr Asp Ser Glu Ser
545
550
555
gat gtc get gca gtt acc gag tcc acc aat
gaa gcc tcg cgc gag cac 1898
Asp Val Ala Ala Val Thr Glu Ser Th
A
r
sn Glu Ala Ser Arg Glu His
560
565
570
cca tct cgc gtg atc att ttg gtg gtt
c
t
gg 1896
ga
aaa act gca gaa aac
Pro Ser Arg Val Ile Ile Leu Val V
l
a
Gly Asp Lys Thr Ala Glu Asn
575 580
585 590
aaa gtt gac gca gaa gtc cgt atc ggt
c
gg 1999
gac get ggt get tcc gag
Lys Val Asp Ala Glu Val Arg Ile Gl
Gl
y
y Asp Ala Gly Ala Ser Glu
595
600
605
atg atc atc atg cat ctc aac gga cct gtc get
M
gac aag ctc cag tat 1992
et Ile Ile Met His Leu Asn Gly Pro V
l
a
Ala Asp Lys Leu Gln Tyr
610
95 615
620
gtc gtc aca cca ctg ttg ctt cct gac acc
ccc atc gtt get tgg tgg 2090
Val Val Thr Pro Leu Leu Leu P
ro Asp Thr Pro Ile Val Ala Trp Trp
625
630
635
cca ggt gaa tca cca aag aat cct tcc c
ag gac cca att gga cgc atc 2088
Pro Gly Glu Ser Pro Lys Asn P
ro Ser Gln Asp Pro Ile Gly Arg Ile
640
695
650
gca caa cga cgc atc act gat get ttg tac gac c
t
Ala Gl
t
g 2136
ga
gac gca cta
n Arg Arg Ile Thr Asp Ala Leu T
r A
y
sp Arg Asp Asp Ala Leu
655 660
665 670
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
gaa gat cgt gtt gag aac tat cac cca ggt gat acc gac atg acg tgg 2lgq
Glu Asp Arg Val Glu Asn Tyr His Pro 680y Asp Thr Asp Met Thr Trp
675 685
gcg cgcctt acccag tggcgg ggactt gttgcctcc ttggat cac 2232
Ala ArgLeu ThrGln TrpArg GlyLeu ValAlatca LeuAsp His
690 695 Ser 700
Ser
cca ccacac agcgaa atcact tccgtg aggctgaccggt gcaagc ggc 2280
Pro ProHis SerGlu IleThr SerVal ArgLeuThrGly AlaSer Gly
705 710 715
agt acctcg gtggat ttgget gcaggc tggttggcgcgg aggctg aaa 2328
Ser ThrSer ValAsp LeuAla AlaGly TrpLeuAlaArg ArgLeu Lys
720 725 730
gtg cctgtg atccgc gaggtg acagat getcccaccgtg ccaacc gat 2376
Val ProVal IleArg GluVal ThrAsp AlaProThrVal ProThr Asp
735 790 795 750
gag tttggt actcca ctgctg getatc cagcgcctggag atcgtt cgc 2429
Glu PheGly ThrPro LeuLeu AlaIle GlnArgLeuGlu IleVal Arg
755 760 765
acc accggc tcgatc atcatc accatc tatgacgetcat accctt cag 2472
Thr ThrGly SerIle IleIle ThrIle TyrAspAlaHis ThrLeu Gln
770 775 780
gta gagatg ccggaa tccggc aatgcc ccatcgctggtg getatt ggt 2520
Val GluMet ProGlu SerGly AsnAla ProSerLeuVal AlaIle Gly
?85 790 795
cgt cgaagt gagtcc gactgc ttgtct gaggagcttcgc cacatg gat 2568
Arg ArgSer GluSer AspCys LeuSer GluGluLeuArg HisMet Asp
800 805 810
cca gatttg ggctac cagcac gcacta tccggcttgtcc agc aag 2616
90 Pro AspLeu GlyTyr GlnHis AlaLeu SerGlyLeuSer gtc Lys
815 820 825 Ser 830
Val
ctg gaaacc gtctaaggaga aa acaacacta gttgatgtagtacgcgca 2668
Leu GluThr Val t tg
cgcatactga agatttggtt gcacaggctg cctccaaatt cattgaggtt gttgaagcag 2728
caactgccaa taatggcacc gcacaggtag tgctcaccgg tggtggcgcc ggcatcaagt 2788
tgctggaaaa gctcagcgtt gatgcggctg accttgcctg ggatcgcatt catgtgttct 2898
tcggcgatga gcgcaatgtc cctgtcagtg attctgagtc caatgagggc caggctcgtg 2908
aggcactgtt gtccaaggtt tctatccctg aagccaacat tcacggatat ggtctcggcg 2968
acgtagatct tgcagaggca gcccgcgctt acgaagctgt gttggatgaa ttcgcaccaa 3028
acggctttga
3038
<210> 7
<211> 519
<212> PRT
<213> Corynebacterium glutamicum AS019
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
Jg
<900>
7
Val Ser ThrAsnThr ThrPro SerSer Trp
1 Thr
Asn
Pro
Leu
Arg
Asp
5 10 15
Pro Gln AspLysArg LeuPro ArgIle Ala
Gly
Pro
Ser
Gly
Met
Val
20 25 30
Ile Phe GlyValThr GlyAsp LeuAla Arg Lys Leu Leu Pro
Lys Al
a
35 40
95
Ile Tyr AspLeuAla AsnArg GlyLeu Leu Pro Gly Phe Ser
Pro Leu
50 55 60
Val Gly TyrGlyArg ArgGlu TrpSer Lys Asp Phe Glu L
Glu s T
y
65 70 yr
75 80
Val Arg AspAlaAla SerAla GlyAla Arg Glu Phe Arg Glu
Thr Asn
85 90 95
Val Trp GluArgLeu AlaGlu GlyMet Glu Val Arg Gly Asn
Phe Phe
100 105 110
Asp Asp AspAlaAla PheAsp AsnLeu Ala Thr Leu Lys Arg
Ala Ile
115 120
125
Asp Lys ThrArgGly ThrAla GlyAsn Trp Tyr Tyr Leu Ser
Ala Ile
130 135 190
Pro Pro AspSerPhe ThrAla ValCys His Leu Glu Arg Ser
14 Gln Gl
y
5 150 155
160
Met Ala GluSerThr GluGlu AlaTrp Arg Val Ile Ile Glu
Arg Lys
165 170 175
Pro Phe GlyHisAsn LeuGlu SerAla His Leu Asn Gln Leu
Glu Val
180 185 190
Asn Ala ValPhePro GluSer SerVal Phe Ile Asp His T
Arg r Leu
195 200 y
205
Gly Lys GluThrVal GlnAsn IleLeu Ala Arg Phe Ala Asn
Leu Gln
210 215 220
Leu Phe GluProLeu TrpAsn SerAsn Tyr Asp His Val Gln
Val Ile
225 230 235
290
Thr Met AlaGluAsp IleGly LeuGly Gly Ala Gly Tyr Tyr
Arg Asp
245 250 255
Gly Ile GlyAlaPro ArgAsp ValIle Gln His Leu Ile Gl
Asn
n Leu
260 265
270
' Leu Ala LeuValAla MetGlu GluPro Ile Phe Val Pro Ala
Ser Al
a
S5 275 280
285
Arg Gln AlaGluLys IleLys ValLeu Ser Thr Lys Pro C
Ala s T
y
290 295 yr
300
Pro Leu AspLysThr SerAla ArgGly
Gln
Tyr
Ala
Ala
Gl
T
Gl
y
305 310 rp
n
315
320
Gly Ser GluLeuVal LysGly LeuArg
Glu
Glu
Asp
Gly
Phe
Asn
Pro
CA 02348365 2001-03-08
WO 01104322 PCT/EP00/06300
I9
325 330 335
Glu SerThr ThrGlu ThrPhe AlaAlaCys ThrLeu GluIle ThrSer
390 395 350
Arg ArgTrp AlaGly ValPro PheTyrLeu ArgThr GlyLys ArgLeu
355 360 365
Gly ArgArg ValThr GluIle AlaValVal PheLys AspAla ProHis
' 10 3?0 375 380
Gln ProPhe AspGly AspMet ThrValSer LeuGly GlnAsn AlaIle
385 390 395
900
Val IleArg ValGln ProAsp GluGlyVal LeuIle ArgPhe GlySer
905 910 915
Lys ValPro GlySer AlaMet GluValArg AspVal AsnMet AspPhe
920 925 430
Ser TyrSer GluSer PheThr GluGluSer ProGlu AlaTyr GluArg
435 440 445
Leu IleLeu AspAla LeuLeu AspGluSer SerLeu PhePro ThrAsn
450 455 960
Glu GluVal GluLeu SerTrp LysIleLeu AspPro IleLeu GluAla
965 970 475
480
Trp AspAla AspGly GluPro GluAspTyr ProAla GlyThr TrpGly
985 990 495
Pro LysSer AlaAsp GluMet LeuSerArg AsnGly HisThr Trp
500 505 510 Arg
Arg Pro
<210> 8
90 <211> 319
<212> PRT
<2I3> Corynebacterium glutamicum AS019
<400> 8
95 Met Ile Phe Glu Leu Pro Asp Thr Thr Thr Gln Gln Ile Ser Lys Thr
1 5 10 15
Leu Thr Arg Leu Arg Glu Ser Gly Thr Gln Val Thr Thr Gly Arg Val
20 25 30
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
Leu Thr Leu Ile Val Val Thr Asp Ser Glu Ser Asp Val Ala Ala Val
35 90 45
5 Thr Glu Ser Thr Asn Glu Ala Ser Arg Glu His Pro Ser Arg Val Ile
~ 50 55 60
Ile Leu Val Val Gly Asp Lys Thr Ala Glu Asn Lys Val Asp Ala Glu
65 70 75 80
Val Arg Ile Gly Gly Asp Ala Gly Ala Ser Glu Met Ile Ile Met His
85 90 95
Leu Asn Gly Pro Val Ala Asp Lys Leu Gln Tyr Val Val Thr Pro Leu
100 105 110
Leu Leu Pro Asp Thr Pro Ile Val Ala Trp Trp Pro Gly Glu Ser Pro
115 120 125
Lys Asn Pro Ser Gln Asp Pro Ile Gly Arg Ile Ala Gln Arg Arg Ile
130 135 140
Thr Asp Ala Leu Tyr Asp Arg Asp Asp Ala Leu Glu Asp Arg Val Glu
145 150 155 160
Asn Tyr His Pro Gly Asp Thr Asp Met Thr Trp Ala Arg Leu Thr Gln
165 170 175
Trp Arg Gly Leu Val Ala Ser Ser Leu Asp His Pro Pro His Ser Glu
180 185 190
Ile Thr Ser Val Arg Leu Thr Gly Ala Ser Gly Ser Thr Ser Val Asp
195 200 205
Leu Ala Ala Gly Trp Leu Ala Arg Arg Leu Lys Val Pro Val Ile Arg
210 215 220
Glu Val Thr Asp Ala Pro Thr Val Pro Thr Asp Glu Phe Gly Thr Pro
225 230 235 240
Leu Leu Ala Ile Gln Arg Leu Glu Ile Val Arg Thr Thr Gly Ser Ile
245 250 255
Ile Ile Thr Ile Tyr Asp Ala His Thr Leu Gln Val Glu Met Pro Glu
260 265 270
Ser Gly Asn Ala Pro Ser Leu Val Ala Ile Gly Arg Arg Ser Glu Ser
275 280 285
Asp Cys Leu Ser Glu Glu Leu Arg His Met Asp Pro Asp Leu Gly Tyr
290 295 300
Gln His Ala Leu Ser Gly Leu Ser Ser Val Lys Leu Glu Thr Val
305 310 315
<210> 9
<211> 960
<212> DNA
<213> Corynebacterium glutamicum AS019
<220>
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
22
atc act tcc gtg agg ctg acc ggt gca agc ggc agt acc tcg gtg gat 629
Ile Thr Ser Val Arg Leu Thr Gly Ala Ser Gly Ser Thr Ser Val Asp
195 200 205
ttg get gcaggc tggttggcg cggagg ctgaaa gtgcctgtg atccgc 672
Leu Ala AlaGly TrpLeuAla ArgArg LeuLys ValProVal IleArg
210 215 220
gag gtg acagat getcccacc gtgcca accgat gagtttggt actcca 720
Glu Val ThrAsp AlaProThr ValPro ThrAsp GluPheGly ThrPro
225 230 235 290
ctg ctg getatc cagcgcctg gagatc gttcgc accaccggc tcgatc 768
Leu Leu AlaIle GlnArgLeu GluIle ValArg ThrThrGly SerIle
245 250 255
atc atc accatc tatgacget catacc cttcag gtagagatg ccggaa 816
Ile Ile ThrIle TyrAspAla HisThr LeuGln ValGluMet ProGlu
260 265 270
tcc ggc aatgcc ccatcgctg gtgget attggt cgtcgaagt gagtcc 864
Ser Gly AsnAla ProSerLeu ValAla IleGly ArgArgSer GluSer
275 280 285
gac tgc ttgtct gaggagctt cgccac atggat ccagatttg ggctac 912
Asp Cys LeuSer GluGluLeu ArgHis MetAsp ProAspLeu GlyTyr
290 295 300
cag cac gcacta tccggcttg tccagc gtcaag ctggaaacc gtctaa 960
Gln His AlaLeu SerGlyLeu SerSer ValLys LeuGluThr Val
305 310 315
<210>
10
<211>
319
<212>
PRT
<213>
Corynebacterium
glutamicum
AS019
<900>
10
Met Ile PheGlu LeuProAsp ThrThr ThrGln GlnIleSer LysThr
1 5 10 15
Leu Thr ArgLeu ArgGluSer GlyThr GlnVal ThrThrGly ArgVal
20 2 5 30
Leu Thr LeuIle ValValThr AspSer GluSer AspValAla AlaVal
35 90 95
Thr Glu Ser Thr Asn Glu Ala Ser Arg Glu His Pro Ser Arg Val Ile
50 55 60
Ile Leu Val Val Gly Asp Lys Thr Ala Glu Asn Lys Val Asp Ala Glu
65 70 75 80
' 55 Val Arg Ile Gly Gly Asp Ala Gly Ala Ser Glu Met Ile Ile Met His
85 90 95
Leu Asn Gly Pro Val Ala Asp Lys Leu Gln Tyr Val Val Thr Pro Leu
100 105 110
Leu Leu Pro Asp Thr Pro Ile Val Ala Trp Trp Pro Gly Glu Ser Pro
115 120 125
CA 02348365 2001-03-08
WO 01/04322 PCT/EP00/06300
23
Lys Asn Ser GlnAsp ProIleGly ArgIle AlaGlnArg ArgIle
Pro
130 135 140
Thr Asp Leu TyrAsp ArgAspAsp AlaLeu GluAspArg ValGlu
Ala
145 150 155 160
Asn Tyr Pro GlyAsp ThrAspMet ThrTrp AlaArgLeu ThrGln
His
165 170 175
Trp Arg Leu ValAla SerSerLeu AspHis ProProHis SerGlu
Gly
180 185 190
Ile Thr Val ArgLeu ThrGlyAla SerGly SerThrSer ValAsp
Ser
195 200 205
Leu Ala Gly TrpLeu AlaArgArg LeuLys ValProVal IleArg
Ala
210 215 220
Glu Val Asp AlaPro ThrValPro ThrAsp GluPheGly ThrPro
Thr
225 230 235 240
Leu Leu Ile GlnArg LeuGluIle ValArg ThrThrGly SerIle
Ala
245 250 255
Ile Ile Ile TyrAsp AlaHisThr LeuGln ValGluMet ProGlu
Thr
260 265 270
Ser Gly Ala ProSer LeuValAla IleGly ArgArgSer GluSer
Asn
275 280 285
Asp Cys Ser GluGlu LeuArgHis MetAsp ProAspLeu GlyTyr
Leu
290 295 300
Gln His Leu SerGly LeuSerSer ValLys LeuGluThr Val
Ala
305 310 315
<210> 11
90 <211> 15
<212> PRT
<213> Corynebacterium
glutamicum
ATCC13032
<900> 11
95 Xaa Xaa Xaa XaaPro XaaXaaTrp XaaAsn ProLeuArg Asp
Xaa
1 5 10 15
50 <210> 12
<211> 15
<212> PRT
<213> Corynebacteriuta
glutamicum
ATCC13032
55 <900> 12
Met Ile Xaa LeuPro AspXaaXaa XaaGln GlnIleSer Lys
Phe
1 5 10 15
